Compositions and methods for enhancing corn traits and yield using genome editing
By genomic modification of the ZmDA1 gene of corn plants, the problem of difficulty in editing the corn genome in the prior art is solved, the effect of increasing yield and improving grain characteristics is achieved, and new engineering and modification of alleles are provided to improve agronomic performance.
Patent Information
- Application Number
- CN202380030459.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-29
- Filing Date
- 2023-03-28
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art is difficult to efficiently and efficiently edit corn plant genomes to increase yield and improve grain characteristics, and effective compositions and methods are lacking.
By genomic modification of the ZmDA1 gene in corn plants, reducing or destroying its activity, including introducing specific modifications such as deletion, insertion, substitution, inversion or repetition in the alleles of the endogenous ZmDA1 gene, using sites Specific genomic modification enzymes such as RNA-guided nucleases, zinc finger nucleases, etc. are targeted for editing.
The effect of increasing corn yield and improving grain characteristics is achieved, such as the increase in grain count per ear, ear area, ear length and grain yield, providing new engineering and modification of alleles to improve agronomic performance.
Smart Images

Figure BDA0005059909980000531 
Figure BDA0005059909980000541 
Figure BDA0005059909980000551
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims priority to U.S. Provisional Application Serial No. 63 / 324,985, filed on March 29, 2022, the entire disclosure of which is incorporated herein by reference.
[0003] Incorporation of Sequence Listing
[0004] 321 kilobytes (in The sequence listing containing a file named "MONS524US_ST26.xml" which was created on March 14, 2023 and contains 59 sequences is incorporated herein by reference in its entirety. Technical Field
[0005] The present disclosure relates to the field of agricultural biotechnology and to methods and compositions for genome editing in plants. In particular, the present invention relates to methods and compositions for producing corn plants that exhibit increased yield and improved kernel characteristics. Background Art
[0006] Precision genome editing technology is a powerful tool for engineering gene expression and regulating protein function, and has the potential to improve important agricultural traits. There remains a need in the art to develop new compositions and methods to effectively and efficiently edit the corn plant genome in order to increase yield and obtain other agronomic benefits. Summary of the invention
[0007] Provided herein are modified corn plants, corn plant seeds, corn plant parts, or corn plant cells comprising a genomic modification that reduces or disrupts ZmDA1 activity compared to ZmDA1 activity in an otherwise identical corn plant, corn plant seed, corn plant part, or corn plant cell lacking the modification. In some embodiments, the modification is present in at least one allele of an endogenous ZmDA1 gene. In specific embodiments, the endogenous ZmDA1 gene encodes a protein having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5%, or 100% sequence identity to SEQ ID NO: 2. In other embodiments, the modification is in a transcribable region of the ZmDA1 gene, non-limiting examples of which include a region of the ZmDA1 gene comprising a coding sequence for a LIM domain, a region of the ZmDA1 gene comprising a coding sequence for a LIM-like domain, a region of the ZmDA1 gene comprising a coding sequence for a C-terminal D1-like domain, an exon region, an intron region, and any combination thereof. In some embodiments, the plant, plant seed, plant part, or plant cell is heterozygous for the modification, while in other embodiments, the plant, plant seed, plant part, or plant cell is homozygous for the modification. In other embodiments, the plant, plant seed, plant part, or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 11-49. In certain embodiments, the modified plant exhibits increased yield, estimated grain yield per plant, estimated grain yield, or any combination thereof, compared to an otherwise identical plant lacking the modification. In other embodiments, the plant, plant seed, plant part or plant cell is defined as comprising a first modification in a first allele of the ZmDA1 gene and a second modification in a second allele of the ZmDA1 gene, the first modification and the second modification being different from each other.
[0008] In certain embodiments, the modified corn plants, corn plant seeds, corn plant parts or corn plant cells provided herein may comprise a modification, wherein the modification comprises a deletion, an insertion, a substitution, an inversion, a duplication or any combination thereof. In some embodiments, for example, the modification is located at about 2369 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO: 3; or located at about 3650 nucleotides or more downstream of the 5' end of the reference sequence SEQ ID NO: 3. Also provided herein are modified plants or their seeds, plant parts, and cells, which comprise a modification that destroys or alters ZmDA1 activity compared to the activity of ZmDA1 in an otherwise identical plant, plant seed, plant part or plant cell lacking the modification. In some embodiments, the modification confers an altered phenotype to the plant compared to the phenotype of an otherwise identical plant lacking the modification. The plant, plant seed, plant part or plant cell may also comprise, for example, a modification in at least one allele of the ZmDA1 gene, wherein the modification is selected from the group consisting of: a deletion of 115 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 11; a deletion of 10 base pairs and a deletion of 4 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 12; a deletion of 7 base pairs and a deletion of 6 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 13; a modification of 8 base pairs and a deletion of 11 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 14; a deletion of 10 base pairs and a deletion of 6 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 15; a deletion of 113 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 16; a deletion of the first 6 base pairs and a deletion of the second 6 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: NO:17; a deletion of 29 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:18; a modification of 111 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:19; a deletion of 10 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:20; a deletion of 10 base pairs and a deletion of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:21; a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:22; a deletion of 12 base pairs and a deletion of 11 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:23; a deletion of 18 base pairs and a deletion of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:24; a deletion of 6 base pairs and a deletion of 4 base pairs,wherein the resulting nucleotide sequence is SEQ ID NO:25; a deletion of 624 base pairs and a deletion of 24 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:26; a deletion of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:27; a deletion of 9 base pairs and a deletion of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:28; a deletion of 1 base pair, wherein the resulting nucleotide sequence is SEQ ID NO:29; a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:30; a deletion of 4 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:31; a deletion of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:32; a modification of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:33; a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:34; a deletion of 112 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:35; a deletion of 3 base pairs and a deletion of 4 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:36; a deletion of 16 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:37; a modification of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:38; a deletion of 5 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:39; a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:40; a deletion of 5 base pairs and a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:41; a deletion of 234 base pairs and a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:42; a deletion of 7 base pairs, an insertion of 64 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:43; a deletion of 234 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:44; a deletion of 7 base pairs, an insertion of 64 base pairs, and a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:45; a deletion of 25 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:46; a deletion of 8 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:47; a deletion of 25 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:48; a deletion of 8 base pairs and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:49; and any combination thereof. In certain embodiments,The modification is contained within the genomic region from nucleotide position 3434 to nucleotide position 6811 of the reference sequence SEQ ID NO: 3. In other embodiments, the modification is contained within the genomic region from about nucleotide position 3650 to about nucleotide position 4437 of the reference sequence SEQ ID NO: 3. In yet other embodiments, the modification is contained within the genomic region from about nucleotide position 3650 to about nucleotide position 4443 of the reference sequence SEQ ID NO: 3. In some embodiments, the modification comprises at least about 1, at least about 3, at least about 5, at least about 10, at least about 15, at least about 20, at least about 25, at least about 30, at least about 35, at least about 40, at least about 45, at least about 50, at least about 55, at least about 60, at least about 65, at least about 70, at least about 75, at least about 80, at least about 85, at least about 90, at least about 95, at least about 100, at least about 125, at least about 150, at least 200, at least 300, at least 600, or at least 650 consecutive nucleotides. In some embodiments, the modification comprising a deletion may also include nucleotide substitutions and / or nucleotide insertions of at least 1, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, or at least 20 consecutive nucleotides surrounding the deletion. The plants, plant seeds, plant parts or plant cells provided herein can also comprise, for example, a chromosomal sequence in a ZmDA1 gene that has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO: 3 in regions other than deletions, insertions, substitutions, inversions or duplications. In certain embodiments, the modification alters the peptidase activity of ZmDA1 compared to the activity of ZmDA1 in an otherwise identical plant lacking the modification. In certain embodiments, the altered phenotype, for example, includes an increase in the number of grains per ear, the number of grains per longitudinal row of an ear, ear area, ear length, yield, grain yield estimate per plant, grain yield estimate, or any combination thereof, compared to the phenotype of an otherwise identical plant lacking the modification. In some embodiments, the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of: SEQ ID NO: 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 and 49. In other embodiments,The modification is contained within the genomic region from nucleotide position 4325 to nucleotide position 4433 of the reference sequence SEQ ID NO:3; the modification is contained within the genomic region from nucleotide position 4107 to nucleotide position 4437 of the reference sequence SEQ ID NO:3; or the modification is contained within the genomic region from nucleotide position 4326 to nucleotide position 4433 of the reference sequence SEQ ID NO:3.
[0009] In certain embodiments, a polynucleotide is provided comprising a sequence selected from the group consisting of SEQ ID NO: 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, and 49. In a specific embodiment, the polynucleotide sequence is a modified endogenous ZmDA1 gene.
[0010] Also disclosed herein is a method for producing a corn plant comprising a modified ZmDA1 gene, the method comprising: a) introducing a modification that reduces or destroys ZmDA1 activity into at least one target site of an endogenous ZmDA1 gene of a corn plant cell; b) identifying and selecting one or more corn plant cells comprising the modification in the ZmDA1 gene in step (a); and c) regenerating at least a first plant from the one or more cells selected in step (b) or their progeny comprising the modification. In some embodiments, the target site is located in a coding region or a non-coding region of the endogenous ZmDA1 gene. In other embodiments, the modification is, for example, in a region of the ZmDA1 gene comprising a coding sequence of a LIM domain, a region of the ZmDA1 gene comprising a coding sequence of a LIM-like domain, a region of the ZmDA1 gene comprising a coding sequence of a C-terminal D1-like domain, an exon region, an intron region, and any combination thereof. In a further embodiment, the modification is facilitated by the presence of at least one site-specific genome modification enzyme in the plant cell. Non-limiting examples of such enzymes include RNA-guided nucleases, zinc finger nucleases, meganucleases, TALE nucleases, recombinases, transposases, and any combination thereof. Examples of RNA-guided nucleases include Cas nucleases, Cpf1 nucleases, or variants of any of them. Some site-specific genome modification enzymes that may find use according to the present disclosure produce at least one strand break at the target site. The methods disclosed herein can be used, for example, to produce any modification according to the present disclosure, including substitutions, insertions, inversions, deletions, duplications, or any combination thereof. In some embodiments, the modification is a deletion, and the deletion comprises a region of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, at least 150, at least 200, at least 300, at least 600, or at least 650 consecutive nucleotides. In some embodiments, the modification comprising a deletion may also include nucleotide substitutions and / or nucleotide insertions of at least 1, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, or at least 20 consecutive nucleotides around the deletion.
[0011] Also provided herein is a method for producing a hybrid corn plant comprising a modified ZmDA1 gene, the method comprising crossing a corn plant comprising the modified ZmDA1 gene with a second non-isogenic corn plant to produce an F1 hybrid corn plant, wherein the modified ZmDA1 gene confers an altered phenotype to the hybrid corn plant compared to the phenotype of the other isogenic hybrid corn plant lacking the modification. In some embodiments, the second non-isogenic corn plant lacks the modified ZmDA1 gene. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] The following drawings form part of this specification and are included to further illustrate certain aspects of the present disclosure. The present disclosure may be better understood by reference to one or more of these drawings in combination with the detailed description of specific embodiments presented herein.
[0013] Figure 1 A shows the ZmDA1 gene sequence (SEQ ID NO: 3), including the marked exons (black arrows) and the 785 bp effective targeting region of the ZmDA1 gene by gRNA (light grey box).
[0014] Figure 1 B shows the protein sequence of ZmDA1 with UIM domain, LIM domain, LIM-like domain and C-terminal DAl-like domain, which are annotated (dark grey and medium grey arrows) and include the region modified by editing (light grey box).
[0015] Figure 2 An alignment of unique, non-redundant sequence edits in ZmDA1 (DA1_edit1-DA1_edit9, respectively; SEQ ID NOs: 11-19) compared to DA1_WT (SEQ ID NO: 3) is shown. Asterisks (*) indicate positions where all edited sequences retain the same bases as the wild type (WT), lacking base deletions or base substitutions / insertions. A dash (-) indicates a base deletion compared to WT. The sequences between the segments labeled 3660 and 4320 (first and second figures) are not included due to the absence of editing in the region. In addition, the consensus sequences upstream of position 3600 and downstream of position 4440 are not included with reference to SEQ ID NO: 3 due to the absence of gene editing in these regions. If present, nucleotide insertions and / or substitutions surrounding the deleted region are shown. The letter case of the bases is arbitrary.
[0016] Figure 3Changes in yield-related traits produced by plants edited with the tested ZmDA1 genes (DA1_edit1-DA1_edit9) are shown. Results are shown as the percentage difference (Δ) between edited and control plants. Dark gray bars indicate significant increases or decreases when the P value is less than 0.2. Light gray bars indicate increases or decreases in yield-related traits when the P value is 0.2 and above. Ear size-related traits were measured by imaging analysis.
[0017] Figure 4 The alignment of sequence edits in ZmDA1 (DA1_edit10 to DA1_edit28, respectively; SEQ ID NOs: 20-38) compared to the genomic sequence of the WT ZmDA1 gene (SEQ ID NO: 3) is shown. The upper figure uses gray arrows to represent the different functional regions of the ZmDA1 gene. The middle figure uses black arrows to represent the exons of the ZmDA1 gene. The lower figure shows the alignment of sequences in the edited region between 3711bp and 4480bp. "DA1_WT" indicates the unedited WT ZmDA1 gene (SEQ ID NO: 3). The dash (-) indicates a base deletion compared to WT. The consensus sequences upstream and downstream are not included due to the absence of editing in these regions. The middle white box containing multiple base pairs indicates an uninterrupted region of base pairs of this length, where the sequence remains consistent with SEQ ID NO:3 (those sequences ending with a base letter on the left side of the box and starting with a base letter on the right side of the same box), or the sequence has a larger deletion compared to SEQ ID NO:3 (those sequences ending with (-) on the left side of the box and starting with (-) on the right side of the box).
[0018] Figure 5The alignment of the detected sequence modifications in ZmDA1 (DA1_edit29-1 to DA1_edit31-4, respectively; SEQ ID NOs:50-59) compared to the genomic sequence of the WT ZmDA1 gene (SEQ ID NO:3) is shown. DA1_edit29-1 to DA1_edit31-4 are schematically visualized by identifying the amplicon sequence of each modification. The upper figure uses gray arrows to represent the different functional regions of the ZmDA1 gene. The middle figure uses black arrows to represent the exons of the ZmDA1 gene. The lower figure shows the alignment of the amplicons in the 4103bp and 4462bp editing regions of SEQ ID NO:3. "DA1_WT" indicates the unedited WT ZmDA1 gene (SEQ ID NO:3). Dashes (-) indicate base deletions compared to WT or spaces in multiple sequence alignments (such as in DA1_WT, DA1_Edit29-1, DA1_Edit29-2, DA1_Edit30-1, DA1_Edit30-3, DA1_Edit30-4, DA1_Edit31-1, DA1_Edit31-2, DA1_Edit31-3, and DA1_Edit31-4) due to the presence of a 64 bp insertion in DA1_Edit30-2. Blank spaces indicate sequences outside the amplicon regions amplified. Consensus sequences upstream and downstream may not be included due to the absence of editing in these regions. The middle white box containing multiple base pairs indicates the region of base pairs of this length, wherein the sequence is consistent with SEQ ID NO:3 (those sequences ending with base letters on the left side of the box and starting with base letters on the right side of the same box), or compared with SEQ ID NO:3, the sequence has a larger deletion (those sequences ending with (-) on the left side of the box and starting with (-) on the right side of the box), or the amplicon terminates in this missing region. The sequence of each amplicon is shown in SEQ ID NO:50-59.
[0019] Sequence Description
[0020] SEQ ID NO: 1 is the polynucleotide coding sequence of the Zea mays DA1 (ZmDA1) gene.
[0021] SEQ ID NO: 2 is the amino acid sequence of ZmDA1 (encoded by SEQ ID NO: 1).
[0022] SEQ ID NO: 3 is the polynucleotide sequence of the ZmDA1 gene, including introns and exons, but excluding 5' and 3' untranslated regions (UTRs).
[0023] SEQ ID NO: 4 is a polynucleotide sequence of a common scaffold compatible with the Cpf1 gene.
[0024] SEQ ID NO: 5 is the polynucleotide sequence of the maize polyubiquitin promoter.
[0025] SEQ ID NO: 6 is a polynucleotide sequence encoding Lachnospiraceae bacterium Cpf1 RNA-guided endonuclease that is codon-optimized for maize.
[0026] SEQ ID NO: 7 is the polynucleotide sequence of a nuclear localization signal from tomato (Solanum lycopersicum).
[0027] SEQ ID NOs: 8-10 are polynucleotide sequences of spacer sequences in guide RNA (gRNA) for editing the transcribable region of the ZmDA1 gene.
[0028] SEQ ID NOs: 11-19 are polynucleotide sequences of alleles of the ZmDA1 gene having various deletions and nucleotide base substitutions or insertions around the deleted regions compared to SEQ ID NO: 3.
[0029] SEQ ID NOs:20-38 are polynucleotide sequences of alleles of the ZmDA1 gene in edited homozygous R1 plants having various segment modifications compared to SEQ ID NO:3.
[0030] SEQ ID NOs:39-49 are polynucleotide sequences of potential homozygous alleles of the ZmDA1 gene obtainable from self-edited R0 plants having various segment modifications compared to SEQ ID NO:3.
[0031] SEQ ID NOs:50-59 are the individual edited polynucleotide sequences detected in edited R0 plants having various segment modifications of the ZmDA1 gene compared to SEQ ID NO:3. DETAILED DESCRIPTION
[0032] Corn (corn / Zea mays) is a valuable field crop. Therefore, the goal of plant breeders is to develop high-yield corn varieties to maximize the amount of grain produced on arable land, and provide food for animals and people. Most commercial corns are produced using hybrid seeds. The cultivation of hybrid corn has significant benefits, for example, it is fully proven that hybrid yields are significantly higher, and the fields planted with hybrids are genetically consistent. At present, North American farmers have planted tens of millions of acres of corn, and there are extensive national and international commercial corn breeding programs. The ongoing goal of these corn breeding programs is to develop corn hybrids with one or more desired characteristics (such as increased yield).
[0033] In one example, corn yield can be increased by increasing important yield determining factors (e.g., grain weight and grain number). Such grain characteristics are particularly important agronomic traits because they can directly affect yield potential. The development of grains (i.e., corn seeds) is controlled by multiple factors. In part, grain development is affected by the ubiquitin pathway gene ZmDA1. Specifically, studies have shown that the ZmDA1 gene and other ubiquitin pathway genes play an important role in regulating cell proliferation and organ size. However, there is still a need to discover and develop new strategies for improving agronomic performance, especially those strategies that can be directly used to develop hybrid corn varieties with one or more desired characteristics.
[0034] The disclosure represents a significant advance in the art, because it provides engineered alleles that confer beneficial phenotypes in corn, and methods for producing the same, thereby providing improvements in key traits that result in increased productivity per plant and plot. Methods and compositions disclosed herein provide the opportunity to produce diversity that conventional plant breeding or random mutagenesis cannot achieve. Therefore, methods and compositions for reducing, destroying or changing ZmDA1 activity in corn are provided herein, which can be used to achieve beneficial results, including, for example, the number of grains per ear, the number of grains per longitudinal row of ear (i.e., kernel rank), ear size-related traits (e.g., ear area, ear length and ear diameter), single grain weight, number of rows of grains, yield, grain yield estimates per plant, grain yield estimates or any combination thereof. In addition, the ability to produce these desired characteristics in corn plants homozygous or heterozygous for engineered alleles provides unique benefits for corn breeders.
[0035] In order to produce such corn plants, in certain embodiments, the present disclosure provides methods and compositions for producing new alleles at the ZmDA1 locus via the editing of the ZmDA1 gene. For example, the transcribable region of the ZMDA1 gene is modified by using an engineered guide RNA as disclosed herein. For example, the region of the coding sequence of the LIM domain, LIM-like domain or C-terminal D1-like domain of the ZmDA1 gene is targeted for mutagenesis. It is shown that a series of edited alleles can be produced at the ZmDA1 locus, including modifications from 1bp to 624bp. Representative edited individuals with a series of modifications of 3bp to 115bp are selected and evaluated. Plants homozygous for the edited alleles are produced by selfing; these homozygous plants are crossed with non-isogenic male corn plant lines to produce hybrid plants. As described herein, hybrid plants heterozygous for the edited alleles show an increase in key yield-related traits, such as the number of grains per ear, grain grade, ear area, ear length, yield, grain yield estimates per plant, and grain yield estimates. The edited alleles at the ZmDA1 locus (as exemplified herein) thus represent a new mechanism for conferring dominant effects to hybrid corn plants, resulting in beneficial agronomic traits. Thus, the present disclosure represents a significant advance in the art because it allows for the generation of new engineered alleles in corn that confer beneficial phenotypes to increase the potential for yield.
[0036] I. Genome Editing
[0037] In certain embodiments, the disclosure provides corn plants, plant parts, plant cells and seeds produced by genome modification using site-specific integration or genome editing. Genome editing can be used to produce one or more edits or mutations at a desired target site in a plant genome, such as to change the expression and / or activity of one or more genes, or to integrate an insertion sequence or a transgenic at a desired position in a plant genome. Any site or locus in a plant genome can be potentially selected for genome editing (or gene editing) or site-specific integration of a transgenic, construct or transcribable DNA sequence. As used herein, a "target site" for genome editing or site-specific integration refers to the position of a polynucleotide sequence in a plant genome, which is bound and cleaved by a site-specific nuclease to introduce a double-strand break (DSB) or a single-stranded nick in the nucleic acid backbone of a polynucleotide sequence and / or its complementary DNA chain in a plant genome. The target site may comprise, for example, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 21, at least 22, at least 23, at least 24, at least 25, at least 26, at least 27, at least 29, or at least 30 consecutive nucleotides. The "target site" of the RNA-guided nuclease may comprise the sequence of any complementary strand of a double-stranded nucleic acid (DNA) molecule or chromosome at the target site. The site-specific nuclease may bind to the target site, for example, via a non-coding guide RNA (e.g., but not limited to, CRISPR RNA (crRNA) or a single guide RNA (sgRNA) as further described herein). The non-coding guide RNA provided herein may be complementary to the target site (e.g., complementary to any strand of a double-stranded nucleic acid molecule or chromosome at the target site). It should be understood that complete identity or complementarity may not be required for the non-coding guide RNA to bind or hybridize to the target site. For example, at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, or at least 8 mismatches (or more) between the target site and the non-coding RNA may be tolerated. "Target site" also refers to the location of a polynucleotide sequence bound and cleaved by any other site-specific nuclease such as zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), meganuclease, etc., which may not be guided by a non-coding RNA molecule, in a plant genome, and the binding and cleavage are used to introduce a DSB or a single-stranded nick into the polynucleotide sequence and / or its complementary DNA strand. As used herein, "target region" or "targeting region" refers to a polynucleotide sequence or region flanked by two or more target sites. Without limitation, in some embodiments, the target region may be subject to mutation, deletion, insertion, substitution, inversion, or duplication.As used herein, "flanking" when used to describe a target region of a polynucleotide sequence or molecule means that two or more target sites of the polynucleotide sequence or molecule surround the target region, with one target site on each side of the target region.
[0038] As used herein, "targeted genome editing technology" refers to any method, protocol or technology that allows precise and / or targeted editing of specific locations in a plant genome (i.e., the editing is primarily or completely non-random) using site-specific nucleases, such as meganucleases, zinc finger nucleases (ZFNs), RNA-guided endonucleases (e.g., CRISPR / Cas9 system or CRISPR / Cpf1 system), TALE (transcription activator-like effector) endonucleases (TALENs), recombinases or transposases. As used herein, "editing" or "genome editing" refers to generating targeted mutations, deletions, insertions, substitutions, inversions, or duplications of at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 75, at least 100, at least 250, at least 500, at least 1000, at least 2500, at least 5000, at least 10,000, or at least 25,000 nucleotides of an endogenous plant genomic nucleic acid sequence. As used herein, "editing" or "genome editing" can also encompass the targeted insertion or site-directed integration of at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 75, at least 100, at least 250, at least 500, at least 750, at least 1000, at least 1500, at least 2000, at least 2500, at least 3000, at least 4000, at least 5000, at least 10,000, or at least 25,000 nucleotides into the endogenous genome of a plant. The singular form "edit" or "genome edit" refers to one such targeted mutation, deletion, insertion, substitution, inversion, or duplication, while multiple "edits" or "genome edits" refer to two or more targeted mutations, deletions, insertions, substitutions, inversions and / or duplications, where each "edit" is introduced via a targeted genome editing technology.
[0039] According to some embodiments, the site-specific nuclease can be co-delivered with a donor template molecule to serve as a template for the desired editing, mutation, or insertion into the genome at the desired target site by repairing the double-strand break (DSB) or nick created by the site-specific nuclease. According to some embodiments, the site-specific nuclease can be co-delivered with a DNA molecule comprising a selectable or screenable marker gene.
[0040] The site-specific nuclease provided herein can be selected from the group consisting of: zinc finger nuclease (ZFN), TALE endonuclease (TALEN), meganuclease, RNA-guided endonuclease (e.g., Cas9 and Cpf1), recombinase, transposase, or any combination thereof. See, for example, Khangale et al. (Plant Biotechnol Rep 10: 327-343, 2016); and Gaj et al. (Trends Biotechnol. 31 (7): 397-405, 2013). Zinc finger nuclease (ZFN) is a synthetic protein consisting of an engineered zinc finger DNA binding domain fused to a cleavage domain (or cleavage half domain), which can be derived from a restriction endonuclease (e.g., FokI). The DNA binding domain can be typical (C2H2) or atypical (e.g., C3H or C4). Depending on the target site, the DNA binding domain may comprise one or more zinc fingers (e.g., 2, 3, 4, 5, 6, 7, 8, 9 or more zinc fingers), but may typically comprise 3-4 (or more) zinc fingers. Multiple zinc fingers in the DNA binding domain may be separated by a linker sequence. By modifying the zinc finger DNA binding domain, ZFNs can be designed to cleave almost any segment of double-stranded DNA. ZFNs form dimers from monomers consisting of a non-specific DNA cleavage domain (e.g., derived from FokI nuclease) fused to a DNA binding domain, which comprises an array of zinc fingers engineered to bind to a target site DNA sequence. Amino acids that promote site-specific binding to a target site at positions -1, +2, +3, and +6 relative to the start of the zinc finger alpha helix can be changed and customized to accommodate specific target sequences. Other amino acids can form a common backbone to produce ZFNs with different sequence specificities.
[0041] Methods and rules for designing ZFNs for targeting and binding to specific target sequences are known in the art. See, for example, U.S. Patent Application Publication Nos. 2005 / 0064474, 2009 / 0117617, and 2012 / 0142062. The FokI nuclease domain may require dimerization to cleave DNA, and therefore, two ZFNs with their C-terminal regions are required to bind to the relative DNA strands (separated by 5-7bp) of the cleavage site. If the two ZF binding sites are palindromic, the ZFN monomer can cut the target site. ZFN as used herein is extensive, and includes monomeric ZFNs that can cleave double-stranded DNA without assistance from another ZFN. The term ZFN can also be used to refer to one or two members of a pair of ZFNs that are engineered to cleave DNA together at the same site. Because the DNA binding specificity of the zinc finger domain can be reengineered using a method in various methods, customized ZFNs can be constructed to target almost any target sequence (e.g., a target sequence at or near a gene in a plant genome) in theory. Publicly available methods for engineering zinc finger domains include context-dependent assembly (CoDA), engineering of oligomeric libraries (OPEN), and modular assembly.
[0042] Transcription activator-like effectors (TALEs) can be engineered to bind virtually any DNA sequence, such as sequences at or near the genomic locus of a gene in a plant. TALEs have a central DNA binding domain consisting of 13 to 28 repeating monomers with 33 to 34 amino acids. Except for the hypervariable amino acid residues at positions 12 and 13, the amino acids of each monomer are highly conserved. The two variable amino acids are referred to as repeat variable di-residues (RVDs). The amino acid pairs NI, NG, HD, and NN of RVDs preferentially recognize adenine, thymine, cytosine, and guanine / adenine, respectively, and the regulation of RVDs can recognize continuous DNA bases. This simple relationship between amino acid sequence and DNA recognition has allowed the engineering of specific DNA binding domains by selecting a combination of repeat segments containing appropriate RVDs.
[0043] TALEN is an artificial restriction enzyme produced by fusing the TALE DNA binding domain to the nuclease domain. In some aspects, the nuclease is selected from the group consisting of: PvuII, MutH, TevI, FokI, AlwI, MlyI, SbfI, SdaI, StsI, CleDORF, Clo051 and Pept071. When each member of a pair of TALEN binds to the DNA site flanked by the target site, the FokI monomer dimerizes and causes double-stranded DNA breaks at the target site. The term TALEN as used herein is extensive and includes monomeric TALENs that can cleave double-stranded DNA without assistance from another TALEN. The term TALEN also refers to one or two members of a pair of TALENs that work together to cleave DNA at the same site.
[0044] In addition to the wild-type FokI cleavage domain, variants of the FokI cleavage domain with mutations have been designed to improve cleavage specificity and cleavage activity. The FokI domain works in a dimer form, so that two constructs with a unique DNA binding domain for a site in the target genome with proper orientation and spacing are required. The number of amino acid residues between the TALEN DNA binding domain and the FokI cleavage domain and the number of bases between two separate TALEN binding sites are both parameters for achieving high activity levels. PvuII, MutH and TevI cleavage domains are useful alternatives for FokI and FokI variants for use with TALE. When coupled with TALE, PvuII acts as a highly specific cleavage domain (see Yank et al., PLoS One 8: e82539, 2013). MutH can introduce a chain-specific nick in DNA (see Gabsalilow et al., Nucleic Acids Research. 41: e83, 2013). TevI introduces double-strand breaks in DNA at the targeted site (see Beurdeley et al., Nature Communications 4: 1762, 2013).
[0045] The relationship between the amino acid sequence and the DNA recognition of the TALE binding domain allows for designable proteins. Software programs such as DNAWorks can be used to design TALE constructs. Other methods for designing TALE constructs are known to those skilled in the art. See Doyle et al. (Nucleic Acids Research 40:W117-122, 2012); Cermak et al. (Nucleic Acids Research 39:e82, 2011); and tale-nt.cac.cornell.edu / about. On the other hand, the TALEN provided herein is capable of generating targeted DSBs.
[0046] Site-specific nucleases may be meganucleases. Meganucleases commonly identified in microorganisms, such as the LAGLIDADG family of homing endonucleases, are unique enzymes with long recognition sequences (>14bp) that are highly active and result in site-specific digestion of target DNA. Engineered forms of naturally occurring meganucleases typically have extended DNA recognition sequences (e.g., 14 to 40bp). Compared to ZFN and TALEN, the engineering of meganucleases can be more challenging because the DNA recognition function and cleavage function of meganucleases are entangled in a single domain. Specialized mutagenesis and high-throughput screening methods have been used to create novel meganuclease variants that recognize unique sequences and have improved nuclease activity.
[0047] The site-specific nuclease may be an RNA-guided nuclease. In one aspect, the targeted genome editing described herein may include the use of an RNA-guided endonuclease. As used herein, "RNA-guided nuclease" refers to an RNA-guided DNA endonuclease associated with a CRISPR system. According to some embodiments, the RNA-guided endonuclease may be selected from the group consisting of: Cas1, Cas1B, Cas2, Cas3, Cas4, Cas5, Cas6, Cas7, Cas8, Cas9 (also known as Csn1 and Csx12), Cas10, Csy1, Csy2, Csy3, Cse1, Cse2, Csc1, Csc2, Csa5, Csn2, Csm2, Csm3 , Csm4, Csm5, Csm6, Cmr1, Cmr3, Cmr4, Cmr5, Cmr6, Csb1, Csb2, Csb3, Csx17, Csx14, Csx10, Csx16, CsaX, Csx3, Csx1, Csx15, Csf1, Csf2, Csf3, Csf4, Cpf1 (also known as Cas12a, see e.g., Safari, F. et al., Cell Biosci 9:36, 2019), CasX, CasY and any homologs or modified forms thereof, and Argonaute proteins (non-limiting examples of Argonaute proteins include Thermus thermophilus Argonaute (TtAgo), Pyrococcus furiosus Argonaute (PfAgo), Natronobacterium gregoryi Argonaute (NgAgo) and any homologs or modified forms thereof). According to some embodiments, the RNA-guided nuclease is Cas9 or Cpf1 enzyme. According to some embodiments, the RNA-guided nuclease is Cpf1 enzyme.
[0048] In its natural situation, the CRISPR system provides immunity to invading foreign nucleic acids for bacteria and archaea and relies on RNA-guided endonucleases to cleave invading DNA or RNA into short sequence fragments and incorporate them into bacterial CRISPR genomic loci. The incorporated short sequence (called "protospacer") and flanking direct repeat sequences are transcribed and processed into CRISPR RNA (crRNA). These crRNAs are hybridized with trans-activated crRNA (tracrRNA) to activate RNA-guided Cas endonucleases to form ribonucleoprotein (RNP) complexes directed to the target site. However, a prerequisite for cleaving the target site is the presence of a conserved genomic protospacer adjacent motif sequence recognized by the Cas endonuclease. "Protospacer adjacent motif" (PAM) herein refers to a short nucleotide sequence adjacent to the target sequence (protospacer) recognized (targeted) by the guidance polynucleotide / Cas endonuclease system described herein. As is known in the art, a PAM may be present in the genome immediately adjacent to the 5' end of a genomic target site sequence and upstream thereof, the genomic target site sequence being complementary to the targeting sequence of the guide RNA - i.e., the targeting sequence is immediately downstream (3') of the sense (+) strand of the genomic target site (relative to the targeting sequence of the guide RNA). See, for example, Wu et al. (Quant Biol. 2 (2): 59-70, 2014). If there is no PAM sequence after the target DNA sequence, the cas endonuclease may not successfully recognize the target DNA sequence. The sequence and length of the PAM sequence herein may vary depending on the Cas endonuclease used. The PAM sequence may be of any length, but is typically 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 nucleotides long.
[0049] CRISPR / Cas9 (which is a CRISPR system from Streptococcus pyogenes) is applicable to eukaryotes and is widely used in gene editing in plants. The CRISPR / Cas9 system requires both crRNA and tracrRNA to guide Cas9 protein recognition and cleavage of target DNA double helix. Cas9 recognizes genomic PAM sequence 5'-NGG-3' (where N is any nucleotide), and when located adjacent to the target site on the sense (+) strand, blunt-end DSB will be generated at the target site, specifically at the 5' end of the PAM site. It has been observed that Cas9 recognizes other PAM sequences, such as 5'-NAG-3' and 5'-NGA-3', which can cause cleavage of non-specific DNA sequences. However, the corresponding sequence of the guide RNA (i.e., downstream (3') of the targeting sequence of the guide RNA immediately adjacent to the guide RNA) is generally not complementary to the genomic PAM sequence.
[0050] Recently, it was found that the CRISPR / Cpf1 system is used for genome editing as an alternative to the CRISPR / Cas9 system. Although CRISPR / Cpf1 works in a manner similar to CRISPR / Cas9, it is a simpler system than CRISPR / Cas9. CRISPR / Cpf1 only requires one crRNA molecule without tracrRNA to cleave DNA. According to Cpf1 orthologs, Cpf1 recognizes genomic PAM sequences 5'-TTTV-3' (wherein V is A, G or C) or 5'-TTN-3'. See, for example, Alok et al. (Front.Plant Sci.11:264,2020). When Cpf1 recognizes a genomic PAM located adjacent to a target site on a sense (+) strand, it will generate a staggered DSB with 4 or 5-nt 5' overhangs at the target site (specifically the 3' end of the PAM site).
[0051] The RNA-guided nuclease can be delivered as a protein with or without a guide RNA, or the guide RNA can be complexed with the RNA-guided nuclease and delivered as a ribonucleoprotein (RNP).
[0052] For RNA-guided endonucleases, guide RNA molecules may also be provided to guide endonucleases to target sites in plant genomes via base pairing or hybridization, thereby generating DSBs or nicks at or near target sites.Guide RNA may be used as gRNA molecules, or as recombinant DNA molecules, constructs or vectors comprising transcribable DNA sequences of coding guide RNAs operably connected to promoters to transform or introduce into plant cells or tissues. As known in the art, guide RNA may include, for example, CRISPR RNA (crRNA), single-stranded guide RNA (sgRNA), or any other RNA molecules that may guide or guide endonucleases to specific target sites in genomes. Prototype CRISPR-associated proteins (Cas9 from Streptococcus pyogenes) naturally bind two kinds of RNA, i.e., CRISPR RNA (crRNA) guides and trans-acting CRISPR RNA (tracrRNA), to assemble CRISPR ribonucleoproteins (crRNPs). "Single-stranded guide RNA" (or "sgRNA") is an RNA molecule comprising crRNA covalently connected to tracrRNA by a linker sequence, which may be expressed as a single RNA transcript or molecule. The guide RNA comprises a guide or targeting sequence (also referred to herein as a "spacer sequence") that is identical or complementary to a target site within the plant genome, such as at or near a gene. Guide RNAs are typically non-coding RNA molecules that do not encode proteins. The guide sequence of a guide RNA may be at least 10 nucleotides in length, such as 12-40 nucleotides, 12-30 nucleotides, 12-20 nucleotides, 12-35 nucleotides, 12-30 nucleotides, 15-30 nucleotides, 17-30 nucleotides, or 17-25 nucleotides in length, or may be about 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or more nucleotides in length. The guide sequence may be at least 95%, at least 96%, at least 97%, at least 99% or 100% identical or complementary to at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 21, at least 22, at least 23, at least 24, at least 25 or more consecutive nucleotides of a DNA sequence at a genomic target site. According to some embodiments, provided herein is a guide RNA comprising a polynucleotide sequence selected from SEQ ID NO: 8, 9 and 10.
[0053] In addition to the guide sequence, the guide RNA may also include one or more other structures or scaffold sequences, which may bind or interact with the RNA-guided endonuclease. Such scaffolds or structural sequences may also interact with other RNA molecules (e.g., tracrRNA). The methods and techniques for designing a targeting construct and guide RNA for genome editing and site-directed integration at a target site in a plant genome using an RNA-guided endonuclease are known in the art.
[0054] As described above, the target gene for genome editing can be the corn DA1 (ZmDA1) gene. In order to modify the ZmDA1 gene by genome editing, the RNA-guided endonuclease can be targeted to the transcribable DNA sequence (i.e., transcribable region) of the gene, such as the region of the coding sequence containing the LIM domain of the ZmDA1 gene, the region of the coding sequence containing the LIM-like domain of the ZmDA1 gene, the region of the coding sequence containing the C-terminal DA1-like domain of the ZmDA1 gene, the exon region, the intron region, or a combination thereof. For example, in certain embodiments, the transcribable DNA sequence targeted for genome editing may contain an exon / intron boundary or may be in close proximity to an exon / intron boundary. If the resulting modification spans an exon / intron boundary, the modification may be referred to as a modification in an exon region and an intron region. For genetic modification of the ZmDA1 gene, a guide RNA can be used that comprises a guide sequence that is at least 90%, at least 95%, at least 96%, at least 97%, at least 99%, or 100% identical or complementary to at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 21, at least 22, at least 23, at least 24, at least 25 or more consecutive nucleotides of SEQ ID NO: 3, or its complement (e.g., 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 or more consecutive nucleotides of SEQ ID NO: 3, or its complement, although alternative splicing and different exon / intron boundaries may occur. As used herein, the term "contiguous" with respect to a polynucleotide or protein sequence means that there are no deletions or gaps in the sequence.
[0055] As used herein, "complementary sequence", "complementary sequence" and "reverse complementary sequence" are used interchangeably with respect to a given sequence. All three terms refer to the reverse complementary sequence of a nucleotide sequence, i.e., a sequence that is complementary to a given sequence in the reverse order of nucleotides.
[0056] As used herein, the term "antisense" refers to a DNA or RNA sequence that is complementary to a specific DNA or RNA sequence. An antisense RNA molecule is a single-stranded nucleic acid that can be combined with a sense RNA strand or sequence or mRNA to form a duplex due to sequence complementarity. The term "antisense strand" refers to a nucleic acid strand that is complementary to a "sense" strand. The "sense strand" of a gene or locus is a DNA or RNA strand (except uracil in RNA and thymine in DNA) that has the same sequence as an RNA molecule transcribed from the gene or locus.
[0057] As is known in the art, a protospacer adjacent motif (PAM) may be present in the genome immediately 5' and upstream of a genomic target site sequence that is complementary to the targeting sequence of the guide RNA - i.e., the targeting sequence is immediately downstream (3') of the sense (+) strand of the genomic target site (relative to the targeting sequence of the guide RNA). See, e.g., Wu et al. (Quant Biol. 2(2): 59-70, 2014). However, the corresponding sequence of the guide RNA (i.e., immediately downstream (3') of the targeting sequence of the guide RNA) may not generally be complementary to the genomic PAM sequence.
[0058] In some embodiments, the site-specific nuclease is a recombinase. Non-limiting examples of recombinases that can be used include serine recombinases connected to a DNA recognition motif, tyrosine recombinases connected to a DNA recognition motif, or any recombinases known in the art that are connected to a DNA recognition motif. In certain embodiments, the site-specific nuclease is a recombinase or a transposase, which can be a DNA transposase or a recombinase connected or fused to a DNA binding domain. Non-limiting examples of recombinases include tyrosine recombinases connected to a DNA recognition motif provided herein, the tyrosine recombinases being selected from the group consisting of Cre recombinases, Gin recombinases, Flp recombinases, and Tnp1 recombinases. In one aspect of the disclosure, the Cre recombinase or Gin recombinase provided herein is tethered to a zinc finger DNA binding domain, a TALE DNA binding domain, or a Cas9 nuclease. On the other hand, a serine recombinase selected from the group consisting of PhiC31 integrase, R4 integrase, and TP-901 integrase can be connected to a DNA recognition motif provided herein. In yet another aspect, a DNA transposase selected from the group consisting of TALE-piggyBac and TALE-Mutator can be linked to a DNA binding domain provided herein.
[0059] Several site-specific nucleases such as recombinases, zinc finger nucleases (ZFNs), meganucleases, and TALENs are not RNA-guided, but rely on their protein structure to determine their target sites to cause DSBs or nicks, or they are fused, tethered, or connected to DNA binding protein domains or motifs. The protein structure of the site-specific nuclease (or fused / connected / tethered DNA binding domain) can target the site-specific nuclease to the target site. According to many of these embodiments, non-RNA-guided site-specific nucleases (such as recombinases, zinc finger nucleases (ZFNs), meganucleases, and TALENs) can be designed, engineered, and constructed according to known methods to target and bind to target sites at or near the genomic loci of endogenous genes in plants, thereby generating DSBs or nicks at such genomic loci. The DSBs or nicks generated by non-RNA-guided site-specific nucleases can lead to knockdown of gene expression via repair of the DSBs or nicks, or changes in the activity of proteins encoded by endogenous genes, which can lead to mutations or insertions of sequences at the sites of the DSBs or nicks by cellular repair mechanisms. Such cellular repair mechanisms can be directed by donor template molecules.
[0060] As used herein, a "donor molecule" that can be a recombinant polynucleotide, DNA or RNA donor template or sequence, a "donor template" or a "donor template molecule" (collectively referred to as a "donor template") is defined as a nucleic acid molecule having a homologous nucleic acid template or sequence (e.g., a homologous sequence) and / or an insertion sequence for site-directed, targeted insertion or recombination into the genome of a plant cell via repair of a nick or DSB in the genome of a plant cell. The donor template may be a separate DNA molecule comprising one or more homologous sequences and / or an insertion sequence for targeted integration, or the donor template may be a sequence portion (i.e., a donor template region) of a DNA molecule that also comprises one or more other expression cassettes, genes / transgenes and / or transcribable DNA sequences. For example, a "donor template" can be used for site-directed integration of a transgene or construct, or as a template for introducing mutations such as insertions, deletions, substitutions, etc. into a target site within the genome of a plant. The targeted genome editing techniques provided herein may include the use of one or more, two or more, three or more, four or more, or five or more donor molecules or templates. The donor template provided herein can comprise at least one, at least two, at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine or at least ten genes or transgenes and / or transcribable DNA sequences. Alternatively, the donor template may not comprise genes, transgenes or transcribable DNA sequences.
[0061] Without limitation, the gene / transgene or transcribable DNA sequence of the donor template may include, for example, insecticide resistance genes, herbicide tolerance genes, nitrogen use efficiency genes, water use efficiency genes, yield increase genes, nutritional quality genes, DNA binding genes, selectable marker genes, RNAi or suppression constructs, site-specific genome modification enzyme genes, single guide RNAs of CRISPR / Cas9 systems, expression cassettes based on geminiviruses, or plant virus expression vector systems. According to other embodiments, the insert sequence of the donor template may include a protein coding sequence or a transcribable DNA sequence encoding a non-coding RNA molecule that can target an endogenous gene for inhibition. The donor template may include a promoter operably linked to a coding sequence, gene, or transcribable DNA sequence, such as a constitutive promoter, a tissue-specific or tissue-preferred promoter, a developmental stage promoter, or an inducible promoter. The donor template may comprise a leader, an enhancer, a promoter, a transcription start site, a 5'-UTR, one or more exons, one or more introns, a transcription termination site, region or sequence, a 3'-UTR and / or a polyadenylation signal, each of which may be operably linked to a coding sequence, a gene (or transgene) or a transcribable DNA sequence encoding a non-coding RNA, a guide RNA, an mRNA and / or a protein. The donor template may be a single-stranded or double-stranded DNA or RNA molecule or a plasmid.
[0062] The "insert sequence" of the donor template is a sequence designed for targeted insertion into the genome of a plant cell and can be of any suitable length. For example, the insert sequence of the donor template can be between 2 and 50,000, between 2 and 10,000, between 2 and 5000, between 2 and 1000, between 2 and 500, between 2 and 250, between 2 and 100, between 2 and 50, between 2 and 30, between 15 and 50, between 15 and 100, between 15 and 500, between 15 and 1000, between 15 and 5000, between 18 and 30, between 18 and 26, between 20 and 26, between 20 and 50, between 20 and 100, between 20 and 250, between 20 000, 100 and 250, 100 and 500, 100 and 1000, 100 and 5000, 100 and 10,000, 250 and 500, 250 and 1000, 250 and 5000, or 250 and 10,000 nucleotides or base pairs. The donor template may also have at least one homology sequence or homology arm, such as two homology arms, to direct the integration of the mutation or insertion sequence into the target site in the plant genome via homologous recombination, wherein the homology sequence or homology arm is identical or complementary to or has a certain percentage of identity or percentage complementarity with the sequence at or near the target site in the plant genome. When the donor template comprises a homology arm as well as an insertion sequence, the homology arm will flank or surround the insertion sequence of the donor template. Each homology arm can be at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 99%, or 100% identical or complementary to at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100, at least 150, at least 200, at least 250, at least 500, at least 1000, at least 2500, or at least 5000 contiguous nucleotides of a target DNA sequence within the plant genome.
[0063] Any method known in the art for site-specific integration can be used with the present disclosure. In the presence of a donor template molecule with an insertion sequence, the insertion sequence can be site-specifically integrated into the plant genome by homologous recombination between the homology arms of the donor template and the plant genome, or by repairing the DSB or nick by non-homologous end joining (NHEJ), to produce a targeted insertion event at the DSB or nick site. Therefore, if a transgenic, transcribable DNA sequence, construct, or sequence is located in the insertion sequence of the donor template, site-specific insertion or integration of the transgenic, transcribable DNA sequence, construct, or sequence can be achieved.
[0064] The introduction of DSB or nick can also be used to introduce targeted mutations in the genome of a plant, including genomic modifications that reduce or destroy ZmDA1 activity compared to the ZmDA1 activity in corn plants, corn plant seeds, corn plant parts or corn plant cells that are otherwise identical to the lack of modification. As used herein, "mutation" refers to a permanent change in the nucleotide sequence of an organism's genome, extrachromosomal DNA or other genetic elements, such as a targeted mutation in a genomic region from nucleotide position 3434 to nucleotide position 6811 with reference to the sequence SEQ ID NO:3. According to this method, mutations such as deletions, insertions, substitutions, inversions and / or duplications can be introduced at the target site via incomplete repair of DSB or nicks to produce genetic modifications in the gene. Even without using a donor template molecule, such mutations can be generated by incomplete repair of the targeted locus. The modification of a gene can be achieved by inducing DSB or nicks at or near the endogenous locus of the gene, which results in the expression of a protein with reduced, destroyed or altered activity compared to a protein expressed by a gene lacking the modification.
[0065] As used herein, when referring to mutations, the term "insertion" refers to the addition of one or more additional nucleotides to DNA. Insertions in the coding region of a gene can alter the splicing of mRNA (splice site mutations) or cause a shift in the reading frame (frameshift), both of which can significantly alter the gene product.
[0066] As used herein, when referring to mutations, the term "deletion" refers to the removal of one or more nucleotides from DNA. Like insertion mutations, these mutations can change the reading frame of a gene.
[0067] As used herein, when referring to a mutation, the term "substitution" refers to the exchange of a single nucleotide for another nucleotide.
[0068] As used herein, the term "inversion" refers to the reversal of the orientation of a chromosome segment. Due to the DNA repair mechanisms that occur at the cleavage and joining sites during the formation of the inversion, the inversion may be accompanied by the deletion of nucleotides at one or both sites flanking the inversion.
[0069] As used herein, the term "duplication" refers to the production of multiple copies of a chromosomal region, thereby increasing the dosage of the genes located therein.
[0070] As used herein, "missense mutation" refers to a single nucleotide change that causes a codon to encode a different amino acid. For example, the codon "CGU" encodes an arginine amino acid. If a missense mutation changes G to U, producing a "CUU" codon, the codon now encodes a leucine amino acid. A missense mutation can be caused by insertion, deletion, substitution, duplication or inversion. Frameshift, missense or nonsense mutations described herein cause a target gene (such as a ZmDA1 gene) to lack function or expression. A "loss of function mutation" is a mutation in the coding sequence of a gene that causes a reduction or complete lack of function of a gene product (usually a protein), such as reduced peptidase activity. A loss of function mutation can, for example, be caused by the truncation of a gene product. The phenotype associated with the allele of a loss of function mutation can be recessive or dominant.
[0071] Similarly, this targeted mutation of gene can be produced with donor template molecule, to guide specific or desired mutation at or near the target site via the repair of DSB or nick.Donor template molecule can comprise homologous sequence, it has or does not have insertion sequence and comprises one or more mutations relative to the targeted genomic sequence at or near the DSB or nick site, such as one or more deletions, insertions, substitutions, inversions and / or repetitions.For example, the targeted mutation of gene can be realized by making at least a portion of gene deletion, insertion, substitution, inversion or repetition, such as by introducing frame shift or premature termination codon into the coding sequence of gene or introducing modification into transcribable DNA sequence.The disappearance of a part of gene can also be introduced by producing DSB or nick at two target sites and causing the disappearance of the intermediate target region of the flanking target site.The modification of targeted gene can cause non-functional protein, interfering protein or the expression of the protein with reduced, destroyed or changed activity compared with the protein expressed by the gene lacking the modified gene.
[0072] In one aspect, the present disclosure provides a modified corn plant or plant seed, plant part or plant cell thereof, comprising a mutant allele of a ZmDA1 gene, wherein the mutant allele comprises at least one genomic modification involving at least 1, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 110, at least 115, at least 125, at least 150, at least 200, at least 300, at least 600 or at least 650 consecutive nucleotides of a transcribable region of an endogenous ZmDA1 gene. The transcribable DNA sequence of the ZmDA1 gene comprises the sequence of SEQ ID NO: 3, which is an approximately 7 kb polynucleotide sequence within the ZmDA1 gene. The genomic modification can be a deletion of a region comprising at least 1, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, at least 20, at least 30, at least 40, at least 50, at least 60, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 110, at least 115, at least 125, at least 150, at least 200, at least 300, at least 600, or at least 650 consecutive nucleotides within the sequence of SEQ ID NO: 3. Such a deletion in SEQ ID NO:3 may include a region spanning: nucleotide 4322 to nucleotide 4436; nucleotide 4324 to nucleotide 4333; nucleotide 4430 to nucleotide 4433; nucleotide 4327 to nucleotide 4333; nucleotide 4429 to nucleotide 4434; nucleotide 3650 to nucleotide 3657; nucleotide 4327 to nucleotide 4337; nucleotide 4324 to nucleotide 4333; nucleotide 4426 to nucleotide 4431; nucleotide 4325 to nucleotide 4437; nucleotide 4325 to nucleotide 4330; nucleotide 4428 to nucleotide 4433; nucleotide 4326 to nucleotide 4354; nucleotide 4429 to nucleotide 4431; or nucleotide 4325 to nucleotide 4435 of SEQ ID NO:3. In one aspect, the genomic modification may also include a deletion and nucleotide substitutions or nucleotide insertions of at least 1, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, or at least 20 consecutive nucleotides surrounding the deletion.Such modifications including nucleotide substitutions or nucleotide insertions in SEQ ID NO:3 may include a region of SEQ ID NO:3 spanning the following: nucleotide 3650 to nucleotide 3657, wherein nucleotide 3657 is a nucleotide substitution or a nucleotide insertion; nucleotide 4325 to nucleotide 4435, wherein nucleotide 4325 is a nucleotide substitution or a nucleotide insertion.
[0073] In one aspect, the mutant allele of the ZmDA1 gene can comprise two or more modifications in the transcribable region of the endogenous ZmDA1 gene. Examples of such mutant alleles of the ZmDA1 gene are disclosed herein and include, for example, an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4324 to nucleotide 4333 of SEQ ID NO:3, and the second deletion spans nucleotide 4430 to nucleotide 4433 of SEQ ID NO:3; an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4327 to nucleotide 4333 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4434 of SEQ ID NO:3; an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 3650 to nucleotide 3657 of SEQ ID NO:3, and the second deletion spans nucleotide 4327 to nucleotide 4337 of SEQ ID NO:3; an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4327 to nucleotide 4333 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4434 of SEQ ID NO:3. NO:3 region, and the second deletion spans nucleotide 4426 to nucleotide 4431 of SEQ ID NO:3; comprising two deleted alleles within the sequence of SEQ ID NO:3, wherein the first deletion spans the region of nucleotide 4325 to nucleotide 4330 of SEQ ID NO:3, and the second deletion spans nucleotide 4428 to nucleotide 4433 of SEQ ID NO:3; and comprising two deleted alleles within the sequence of SEQ ID NO:3, wherein the first deletion spans the region of nucleotide 4326 to nucleotide 4354 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4431 of SEQ ID NO:3; comprising two modified alleles within the sequence of SEQ ID NO:3, wherein the first modification comprises deletion and nucleotide substitution or nucleotide insertion and spans the region of nucleotide 3650 to nucleotide 3657 of SEQ ID NO:3, wherein nucleotide 3657 is a nucleotide substitution or a nucleotide insertion, and the second modification is a nucleotide substitution or a nucleotide insertion spanning SEQ ID NO:3; NO:3 has a deletion from nucleotide 4327 to nucleotide 4337.
[0074] In one aspect, the mutant allele of the ZmDA1 gene can include, for example, an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4328 to nucleotide 4337 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4431 of SEQ ID NO:3; an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4326 to nucleotide 4335 of SEQ ID NO:3, and the second deletion spans nucleotide 4426 to nucleotide 4434 of SEQ ID NO:3; an allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4327 to nucleotide 4434 of SEQ ID NO:3; an allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4324 to nucleotide 4335 of SEQ ID NO:3, and the second deletion spans nucleotide 4427 to nucleotide 4437 of SEQ ID NO:3; NO:3 comprises two deleted alleles within the sequence, wherein the first deletion spans the region from nucleotide 4319 to nucleotide 4336 of SEQ ID NO:3, and the second deletion spans nucleotide 4428 to nucleotide 4434 of SEQ ID NO:3; the sequence of SEQ ID NO:3 comprises two deleted alleles, wherein the first deletion spans the region from nucleotide 4334 to nucleotide 4339 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4432 of SEQ ID NO:3; the sequence of SEQ ID NO:3 comprises two deleted alleles, wherein the first deletion spans the region from nucleotide 3719 to nucleotide 4342 of SEQ ID NO:3, and the second deletion spans nucleotide 4414 to nucleotide 4437 of SEQ ID NO:3; the sequence of SEQ ID NO:3 comprises a deleted allele, wherein the deletion spans the region from nucleotide 4328 to nucleotide 4335 of SEQ ID NO:3; the sequence of SEQ ID NO:3 comprises two deleted alleles, wherein the first deletion spans the region from nucleotide 4334 to nucleotide 4339 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4432 of SEQ ID NO:3. NO:3, and the second deletion spans the region from nucleotide 4326 to nucleotide 4334 of SEQ ID NO:3; the allele comprising a deletion within the sequence of SEQ ID NO:3, wherein nucleotide 4429 of SEQ ID NO:3 is deleted; the allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4426 to nucleotide 4435 of SEQ ID NO:3;A deleted allele is included in the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4431 to nucleotide 4434 of SEQ ID NO:3; A deleted allele is included in the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4427 to nucleotide 4433 of SEQ ID NO:3; A modified allele is included in the sequence of SEQ ID NO:3, wherein the modification includes a deletion and a nucleotide substitution or a nucleotide insertion spanning the region from nucleotide 4428 to nucleotide 4434 of SEQ ID NO:3; A deleted allele is included in the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4326 to nucleotide 4433 of SEQ ID NO:3; A deleted allele is included in the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4331 to nucleotide 4442 of SEQ ID NO:3; Two deleted alleles are included in the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4427 to nucleotide 4433 of SEQ ID NO:3. NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4432 of SEQ ID NO:3; comprising a deleted allele within the sequence of SEQ ID NO:3, wherein the deletion spans the region of nucleotide 4421 to nucleotide 4436 of SEQ ID NO:3; comprising a modified allele within the sequence of SEQ ID NO:3, wherein the modification includes a deletion and a nucleotide substitution or a nucleotide insertion spanning the region of nucleotide 4428 to nucleotide 4435 of SEQ ID NO:3; comprising a deleted allele within the sequence of SEQ ID NO:3, wherein the deletion spans the region of nucleotide 4429 to nucleotide 4433 of SEQ ID NO:3; comprising a deleted allele within the sequence of SEQ ID NO:3, wherein the deletion spans the region of nucleotide 4325 to nucleotide 4334 of SEQ ID NO:3; comprising a deleted allele within the sequence of SEQ ID NO:3, wherein the deletion spans the region of nucleotide 4107 to nucleotide 4340 of SEQ ID NO:3; NO:3 comprises a modified allele, wherein the modification comprises a deletion and a nucleotide substitution or a nucleotide insertion spanning a region from nucleotide 4327 to nucleotide 4335 of SEQ ID NO:3; an allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans a region from nucleotide 4431 to nucleotide 4433 of SEQ ID NO:3; an allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans a region from nucleotide 4428 to nucleotide 4437 of SEQ ID NO:3;The allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4326 to nucleotide 4350 of SEQ ID NO:3; the allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4328 to nucleotide 4335 of SEQ ID NO:3; the allele comprising a modification within the sequence of SEQ ID NO:3, wherein the modification comprises a deletion and a nucleotide substitution or a nucleotide insertion spanning the region from nucleotide 4425 to nucleotide 4433 of SEQ ID NO:3; the allele comprising a deletion within the sequence of SEQ ID NO:3, wherein the deletion spans the region from nucleotide 4429 to nucleotide 4431 of SEQ ID NO:3; the allele comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4325 to nucleotide 4334 of SEQ ID NO:3, and the second deletion spans the region from nucleotide 4429 to nucleotide 4433 of SEQ ID NO:3; NO:3 comprises two deleted alleles within the sequence, wherein the first deletion spans the region from nucleotide 4107 to nucleotide 4340 of SEQ ID NO:3, and the second deletion spans nucleotide 4428 to nucleotide 4437 of SEQ ID NO:3; comprises two modified alleles within the sequence of SEQ ID NO:3, wherein the first modification comprises a deletion and a nucleotide substitution or a nucleotide insertion across the region from nucleotide 4327 to nucleotide 4335 of SEQ ID NO:3, and the second modification comprises a deletion across the region from nucleotide 4431 to nucleotide 4433 of SEQ ID NO:3; comprises two deleted alleles within the sequence of SEQ ID NO:3, wherein the first deletion spans the region from nucleotide 4107 to nucleotide 4340 of SEQ ID NO:3, and the second deletion spans nucleotide 4431 to nucleotide 4433 of SEQ ID NO:3; comprises two modified alleles within the sequence of SEQ ID NO:3, wherein the first modification comprises a deletion and a nucleotide substitution or a nucleotide insertion across the region from nucleotide 4327 to nucleotide 4335 of SEQ ID NO:3, and the second modification comprises a deletion across the region from nucleotide 4431 to nucleotide 4433 of SEQ ID NO:3 NO:3, and the second modification includes a deletion spanning a region from nucleotide 4428 to nucleotide 4437 of SEQ ID NO:3; Two deleted alleles are included within the sequence of SEQ ID NO:3, wherein the first deletion spans a region from nucleotide 4326 to nucleotide 4350 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4431 of SEQ ID NO:3;The alleles comprising two modifications within the sequence of SEQ ID NO:3, wherein the first modification comprises a deletion spanning the region of nucleotide 4328 to nucleotide 4335 of SEQ ID NO:3, and the second modification comprises a deletion and a nucleotide substitution or a nucleotide insertion spanning the region of nucleotide 4425 to nucleotide 4433 of SEQ ID NO:3; The alleles comprising two modifications within the sequence of SEQ ID NO:3, wherein the first modification comprises a deletion spanning the region of nucleotide 4326 to nucleotide 4350 of SEQ ID NO:3, and the second modification comprises a deletion and a nucleotide substitution or a nucleotide insertion spanning the region of nucleotide 4425 to nucleotide 4433 of SEQ ID NO:3; The alleles comprising two deletions within the sequence of SEQ ID NO:3, wherein the first deletion spans the region of nucleotide 4328 to nucleotide 4335 of SEQ ID NO:3, and the second deletion spans nucleotide 4429 to nucleotide 4431 of SEQ ID NO:3.;
[0075] Other targeted modifications can be made in transcribable regions to generate new alleles in the ZmDA1 gene. For example, one or more modification sites can be located at about 2375 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3; or one or more modification sites can be located at about 2369 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3. One or more modification sites can also be located at about 3650 nucleotides or more downstream of the 5' end of the reference sequence SEQ ID NO:3. In one aspect, one or more modifications can be made in a DNA region spanning nucleotide position 3434 to nucleotide position 6811 of SEQ ID NO:3 to generate new alleles in the ZmDA1 gene. On the other hand, one or more modifications can be made in a DNA region spanning about nucleotide position 3650 to about nucleotide position 4437 of SEQ ID NO:3 to generate new alleles in the ZmDA1 gene. In another aspect, modifications can be made within the genomic region from about nucleotide position 3650 to about nucleotide position 4443 of the reference sequence SEQ ID NO: 3 to generate a novel allele in the ZmDA1 gene. In yet another aspect, modifications can be made within the genomic region from about nucleotide position 3719 to about nucleotide position 4443 of the reference sequence SEQ ID NO: 3 to generate a novel allele in the ZmDA1 gene.
[0076] On the other hand, in certain embodiments, the modified corn plants, corn plant seeds, corn plant parts or corn plant cells provided herein may comprise at least one modification, wherein the modification comprises a deletion, insertion, substitution, inversion, duplication or any combination thereof in at least one allele of the endogenous ZmDA1 gene. On the other hand, the modification is defined by at least one of SEQ ID NOs: 11-49. For example, the modified plants, plant seeds, plant parts or plant cells provided herein may comprise a modification in at least one allele of the ZmDA1 gene, wherein the modification comprises a deletion of 115 base pairs defined by SEQ ID NO: 11.
[0077] On the other hand, the present disclosure provides a modified corn plant or its plant seed, plant part or plant cell comprising a mutant allele of a ZmDA1 gene, wherein the mutant allele comprises one or more junction sequences, wherein the junction sequence is at least 30, at least 60, at least 100 nucleotides at the junction site. As used herein, a "junction site" is a junction between nucleotide sequences at a site of a deletion, insertion, substitution, inversion, duplication or any combination thereof. In the case of a deletion, the junction site is a junction at the deletion site of a sequence previously flanked by a deletion. For example, in the case of a deletion of 115 base pairs from nucleotide 4322 to nucleotide 4436, compared to the reference sequence SEQ ID NO: 3 described herein, the junction site will be between nucleotide 4321 and nucleotide 4437. In the case of a modification including a deletion and a nucleotide substitution or nucleotide insertion around the deletion, the junction site is a junction at the modification site previously flanked by a deletion. For example, in the case of a modification of 8 base pairs from nucleotide 3650 to nucleotide 3657, wherein nucleotide 3657 is a nucleotide substitution or nucleotide insertion compared to the reference sequence SEQ ID NO: 3 described herein, the junction site will be between nucleotide 3649 and nucleotide 3657. In the case of an insertion, substitution, inversion, or duplication, the junction site is the point of connection between the sequence of the insertion, substitution, inversion, or duplication and the flanking DNA sequence. In the case of an insertion, substitution, inversion, or duplication, one junction site is found at the 5' end of the insertion, substitution, inversion, or duplication, and another junction site is found at the 3' end of the insertion, substitution, inversion, or duplication. "Junction sequence" refers to a DNA sequence of any length that spans a junction site. The junction sequence can comprise at least 3 nucleotides, at least 10 nucleotides, at least 15 nucleotides, at least 20 nucleotides, at least 25 nucleotides, at least 30 nucleotides, at least 40 nucleotides, at least 50 nucleotides, at least 60 nucleotides, at least 70 nucleotides, at least 80 nucleotides, at least 90 nucleotides, at least 100 nucleotides, at least 200 nucleotides, at least 300 nucleotides, or more nucleotides.As an illustrative example, in the case of a deletion of 115 base pairs from nucleotide 4322 to nucleotide 4436, compared to the reference sequence SEQ ID NO: 3 described herein, the junction sequence can be defined in certain embodiments as comprising the following nucleotide sequence: nucleotide 4317 to nucleotide 4326 of SEQ ID NO: 11, nucleotide 4312 to nucleotide 4331 of SEQ ID NO: 11, nucleotide 4307 to nucleotide 4336 of SEQ ID NO: 11, nucleotide 4302 to nucleotide 4341 of SEQ ID NO: 11, nucleotide 4297 to nucleotide 4346 of SEQ ID NO: 11, nucleotide 4292 to nucleotide 4351 of SEQ ID NO: 11, nucleotide 4287 to nucleotide 4356 of SEQ ID NO: 11, nucleotide 4282 to nucleotide 4361 of SEQ ID NO: 11, nucleotide 4277 to nucleotide 4366 of SEQ ID NO: 11, nucleotide 4272 to nucleotide 4371 of SEQ ID NO: 11, Nucleotide 4222 to nucleotide 4421 of SEQ ID NO:11 or nucleotide 4172 to nucleotide 4471 of SEQ ID NO:11.
[0078] II. Constructs for genome editing
[0079] Recombinant DNA constructs and vectors are provided, comprising polynucleotide sequences encoding site-specific nucleases, such as zinc finger nucleases (ZFNs), meganucleases, RNA-guided endonucleases, TALE endonucleases (TALENs), recombinases or transposases, wherein the coding sequence is operably linked to a plant-expressible promoter. For RNA-guided endonucleases, recombinant DNA constructs and vectors are also provided, comprising polynucleotide sequences encoding guide RNAs, wherein the guide RNAs comprise a guide sequence of sufficient length, and the guide sequence has a certain percentage of identity or complementarity with a target site in a plant genome (such as at or near a targeting ZmDA1 gene). The polynucleotide sequences of the recombinant DNA constructs and vectors encoding site-specific nucleases or guide RNAs can be operably linked to a plant-expressible promoter (such as an inducible promoter, a constitutive promoter, a tissue-specific promoter, etc.).
[0080] In one aspect, a vector comprising a polynucleotide encoding a site-specific nuclease and optionally one or more, two or more, three or more, or four or more gRNAs is provided to a plant cell by a transformation method known in the art (e.g., but not limited to, particle bombardment, PEG-mediated protoplast transfection, or Agrobacterium-mediated transformation). In one aspect, a vector comprising a polynucleotide encoding a Cpf1 nuclease and optionally one or more, two or more, three or more, or four or more gRNAs is provided to a plant cell by a transformation method known in the art (e.g., but not limited to, particle bombardment, PEG-mediated protoplast transfection, or Agrobacterium-mediated transformation). In another aspect, a vector comprising a polynucleotide encoding a Cpf1 and optionally one or more, two or more, three or more, or four or more crRNAs is provided to a cell by a transformation method known in the art (e.g., but not limited to, viral transfection, particle bombardment, PEG-mediated protoplast transfection, or Agrobacterium-mediated transformation).
[0081] As used herein, "gene" refers to a nucleic acid sequence that forms a hereditary and functional unit and encodes one or more sequence-related RNAs and / or polypeptide molecules. A gene generally contains a coding region that is operably linked to an appropriate regulatory sequence for expression of a regulatory gene product (e.g., a polypeptide or functional RNA). A gene may have various sequence elements, including but not limited to promoters, untranslated regions (UTRs), exons, introns, and other upstream or downstream regulatory sequences.
[0082] As used herein, "locus" is the chromosomal locus or region where a polymorphic nucleic acid, a trait determinant, a gene or a marker is located."Locus" can be shared by two homologous chromosomes to refer to their corresponding locus or region. As used herein, "allele" refers to a gene or an alternative nucleic acid sequence at a specific locus (for example, a gene or locus is different from the nucleic acid sequence of other alleles of the same gene or locus). Such alleles can be considered as (i) wild-type, or (ii) if one or more mutations or editing are present in the nucleic acid sequence of a mutant allele relative to a wild-type allele, it is considered as a mutant. Relative to a wild-type allele, a mutant of a gene or an edited allele can have an activity reduced, destroyed, changed or eliminated, or a gene expression level reduced or eliminated. For example, a mutant or edited allele of the ZmDA1 gene can have a deletion in a transcribable region of the endogenous ZmDA1 gene, which reduces, destroys or changes the activity of a protein encoded by the mutant allele compared to the activity of a protein encoded by a wild-type allele in an otherwise identical corn plant. For diploid organisms such as corn, a first allele may appear on one chromosome, and a second allele may appear on the same locus on a second homologous chromosome. If one allele at a locus on a chromosome of a plant is a mutant or edited allele, and the other corresponding allele on the homologous chromosome of the plant is wild-type, the plant is described as being heterozygous for the mutant or edited allele. However, if both alleles at a locus are mutants or edited alleles, the plant is described as being homozygous or biallelic for the mutant or edited allele. As used herein, the term "homozygous" refers to a genotype comprising two identical alleles at a given locus of a diploid genome. Considering that corn is a diploid organism, CRISPR-mediated gene editing can produce double alleles (i.e., different editing of the same locus on the corresponding homologous chromosome) editing, thereby producing a genotype comprising two non-identical mutant alleles at a given locus in the diploid genome of an R0 plant. When used in the case of edited alleles, plants comprising such genotypes may also be referred to as comprising heteroallelic combinations or double allele editing.
[0083] As used herein, "wild-type gene" or "wild-type allele" refers to a gene or allele that has the most common sequence or genotype in a particular plant species, or another sequence or genotype that has only natural variations, polymorphisms or other silent mutations that do not significantly affect the expression and activity of the gene or allele relative to the most common sequence or genotype. In fact, a "wild-type" gene or allele does not contain a variation, polymorphism or any other type of mutation that substantially affects the normal function, activity, expression or phenotypic outcome of the gene or allele relative to the most common sequence or genotype.
[0084] In general, the term "variant" refers to a molecule that has some synthetic or naturally occurring differences in its nucleotide or amino acid sequence, respectively, compared to a reference (natural) polynucleotide or polypeptide. These differences include substitutions, insertions, deletions, inversions, duplications, or any desired combination of these changes in the natural polynucleotide or amino acid sequence.
[0085] As used herein, the term "expression" refers to the biosynthesis of a gene product in a cell, tissue, organ or organism such as a plant, plant part, or plant cell, tissue or organ, and generally the transcription and / or translation of a nucleotide sequence such as an endogenous gene, a heterologous gene, a transgene or an RNA and / or protein coding sequence.
[0086] The term "recombinant" with respect to polynucleotide (DNA or RNA) molecules, proteins, constructs, vectors, etc. refers to a polynucleotide or protein molecule or sequence that is artificial and not usually found in nature, and / or exists in a situation where the molecule or sequence is not usually found in nature, including a polynucleotide (DNA or RNA) molecule, protein, construct, etc. comprising a combination of two or more polynucleotide or protein sequences that would not naturally exist together in the same manner without human intervention, such as a polynucleotide molecule, protein, construct, etc. comprising at least two operably linked but heterologous polynucleotide or protein sequences. For example, the term "recombinant" may refer to any combination of two or more DNA or protein sequences in the same molecule (e.g., plasmid, construct, vector, chromosome, protein, etc.), wherein such a combination is artificial and not usually found in nature. As used in this definition, the phrase "not usually found in nature" means not found in nature without artificial introduction. A recombinant polynucleotide or protein molecule, construct, etc. may comprise a polynucleotide or protein sequence that is (i) isolated from other polynucleotide or protein sequences that are found proximal to each other in nature, and / or (ii) adjacent to (or contiguous with) other polynucleotide or protein sequences that are not naturally proximal to each other.
[0087] Such recombinant polynucleotide molecules, proteins, constructs, etc. may also refer to polynucleotides or protein molecules or sequences that have been genetically engineered and / or constructed outside the cell. For example, recombinant DNA molecules may include any engineered or artificial plasmids, vectors, etc., and may include linear or circular DNA molecules. Except for plant selectable marker genes, such plasmids, vectors, etc. may contain various maintenance elements, including prokaryotic replication origins and selectable markers, and one or more transgenics or expression cassettes. The term "operably connected" refers to the functional connection between a promoter or other regulatory elements and a gene (or transgenic)-related transcribable DNA sequence or a coding sequence, so that promoters, etc. operate or work to start, assist, influence, cause and / or promote transcription and expression of a related transcribable DNA sequence or a coding sequence at least in some cells, tissues, developmental stages, and / or conditions.
[0088] Reference to "isolated DNA molecules" or "isolated polynucleotides" or equivalent terms or phrases in this application is intended to mean that the DNA molecules or polynucleotides are DNA molecules that exist alone or in combination with other compositions, but are not in their natural environment. For example, as long as a nucleic acid element naturally occurring in the DNA of the genome of an organism (such as a coding sequence, an intron sequence, a non-translated leader sequence, a promoter sequence, a transcription termination sequence, etc.) is located within the genome of the organism and at a position within the genome where it naturally occurs, the element is not considered to be "isolated". However, as long as each of these elements and sub-portions of these elements are not within the genome of the organism and are not at a position within the genome where it naturally occurs, the element is "isolated" within the scope of the present disclosure. Similarly, a nucleotide sequence encoding a protein or any naturally occurring variant of the protein will be an isolated nucleotide sequence, as long as the nucleotide sequence is not in the DNA of the organism where the sequence encoding the protein naturally occurs. For the purposes of this disclosure, a synthetic nucleotide sequence encoding the amino acid sequence of a naturally occurring protein will be considered to be isolated. For the purposes of this disclosure, any transgenic nucleotide sequence, i.e., a nucleotide sequence of DNA that is inserted into the genome of a plant or bacterial cell or present in an extrachromosomal vector, will be considered an isolated nucleotide sequence, whether it is present in a plasmid or similar construct used to transform cells, in the genome of a plant or bacterium, or in detectable amounts in a tissue, progeny, biological sample, or commercial product derived from a plant or bacterium.
[0089] As generally understood in the art, the term "promoter" may generally refer to a DNA sequence that contains an RNA polymerase binding site, a transcription start site and / or a TATA box and assists or promotes the transcription and expression of a related transcribable polynucleotide sequence and / or a gene (or transgenic). A promoter may be artificially produced, varied or derived from a known or naturally occurring promoter sequence or other promoter sequence. A promoter may also include a chimeric promoter comprising a combination of two or more heterologous sequences. Therefore, the promoter of the present disclosure may include a variant or fragment of a promoter sequence that is similar in composition to other promoter sequences known or provided herein, but not identical. A promoter or its variant or fragment provided herein may include a "minimal promoter" that provides a basal level of transcription and is composed of a TATA box or an equivalent DNA sequence for identifying and binding to an RNA polymerase II complex to initiate transcription. Promoters may be classified according to a variety of standards related to the expression pattern of a related coding or transcribable sequence or gene (including a transgenic) that is operably connected to a promoter, such as constitutive, developmental, tissue-specific, inducible, etc. A promoter that drives expression in all or most tissues of a plant is referred to as a "constitutive" promoter. The promoter that drives expression during certain periods or stages of development is called "developmental" promoter. The promoter that drives the expression enhancement in certain tissues of plants relative to other plant tissues is called "tissue enhancement" or "tissue preferred" promoter. Therefore, "tissue preferred" promoters cause relatively high or preferential expression in the specific tissues of plants, but the expression level is low in other tissues of plants. Promoters that express in the specific tissues of plants and hardly express or do not express in other plant tissues are called "tissue specific" promoters. "Inducible" promoters are promoters that initiate transcription in response to environmental stimuli such as cold, drought or illumination or other stimuli such as wound or chemical application. Promoters can also be classified as such as heterologous, homologous, chimeric, synthetic, etc. with respect to their source.
[0090] As used herein, "plant expressible promoter" refers to a promoter that can initiate, assist, influence, cause and / or promote the transcription and expression of its associated transcribable DNA sequence, coding sequence or gene in plant cells or tissues.
[0091] The term "heterologous" with respect to a promoter or other regulatory sequence with respect to a related polynucleotide sequence (e.g., a transcribable DNA sequence or a coding sequence or gene) means that the promoter or regulatory sequence is not operably linked to such related polynucleotide sequence in nature without artificial introduction, for example, the promoter or regulatory sequence has a different origin than the related polynucleotide sequence and / or the promoter or regulatory sequence does not naturally occur in the plant species to be transformed with the promoter or regulatory sequence.
[0092] As used herein, "endogenous gene" or "endogenous locus" refers to a gene or locus at its natural and original chromosomal location. As used herein, "endogenous ZmDA1 gene" refers to the ZmDA1 genomic locus at its original chromosomal location.
[0093] As used herein, in the context of a protein-coding gene, "exon" refers to a segment of a DNA or RNA molecule that contains the information encoding a protein or polypeptide sequence.
[0094] As used herein, an "intron" of a gene refers to a segment of a DNA or RNA molecule that does not contain information encoding a protein or polypeptide and that is first transcribed into an RNA sequence but is then spliced out from the mature RNA molecule.
[0095] As used herein, the "untranslated region (UTR)" of a gene refers to a segment of an RNA molecule or sequence (e.g., an mRNA molecule) that is expressed from a gene (or transgene), but excludes the exon and intron sequences of the RNA molecule. "Untranslated region (UTR)" also refers to a DNA segment or sequence that encodes such a UTR segment of an RNA molecule. Depending on whether the untranslated region is located at the 5' or 3' end of the DNA or RNA molecule or sequence relative to the coding region of the DNA or RNA molecule or sequence (i.e., upstream (5') or downstream (3') of the exon and intron sequences, respectively), it can be a 5'-UTR or a 3'-UTR.
[0096] As used herein, "transcribeable region" or "transcribeable DNA sequence" refers to a nucleic acid sequence that is expressed by a gene (or transgene).
[0097] As used herein, "transcription termination sequence" refers to a nucleic acid sequence that contains a signal that triggers the release of a newly synthesized transcribed RNA molecule from the RNA polymerase complex and marks the end of transcription of a gene or locus.
[0098] As used herein, the terms "percent identity", "% identity" or "percent identity" with respect to two or more nucleotide or protein sequences are calculated by (i) comparing two optimally aligned sequences (nucleotides or proteins) over a comparison window, (ii) determining the number of positions at which the same nucleic acid base (for nucleotide sequences) or amino acid residue (for proteins) is present in both sequences to yield the number of matched positions, (iii) dividing the number of matched positions by the total number of positions in the comparison window, and then (iv) multiplying this quotient by 100% to yield the percent identity. If the "percent identity" is calculated relative to a reference sequence without specifying a particular comparison window, the percent identity is determined by dividing the number of positions matched over the alignment region by the total length of the reference sequence. Thus, for purposes of this application, when two sequences (query and target) are optimally aligned (taking into account gaps in their alignment), the "percent identity" of the query sequence is equal to the number of positions that are identical between the two sequences divided by the total number of positions in the query sequence over its length (or comparison window), then multiplied by 100%. When using percentages of sequence identity to refer to proteins, we recognize that residue positions that are not identical often differ by conservative amino acid substitutions, in which amino acid residues are substituted with other amino acid residues having similar chemical properties (e.g., charge or hydrophobicity), and thus do not change the functional properties of the molecule. When sequences differ in conservative substitutions, the percentage of sequence identity can be adjusted upward to correct for the conservative nature of the substitutions. Sequences that differ due to such conservative substitutions are referred to as having "sequence similarity" or "similarity." A sequence having a certain percentage identity to a base sequence can exhibit the activity of the base sequence.
[0099] The degeneracy of the genetic code provides the possibility of replacing at least one base of the protein coding sequence of a gene with a different base without causing a change in the amino acid sequence of the polypeptide produced from the gene. When optimally aligned, homologous proteins or their corresponding nucleotide sequences are generally at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 92%, at least about 93%, at least about 94%, at least about 95%, at least about 96%, at least about 97%, at least about 98%, at least about 99%, or even at least about 99.5% identical to the full length of the protein or its corresponding nucleotide sequence identified as being associated with conferring an altered phenotype when expressed in a plant cell. According to an embodiment of the present invention, the ZmDA1 gene encodes a protein having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:2.
[0100] Homologs are inferred from sequence similarity by comparing protein sequences, for example manually or by using computer-based tools. Various pairwise or multiple sequence alignment algorithms and programs are known in the art for comparing sequence identity or similarity between two or more nucleotide or protein sequences, such as ClustalW or Basic Local Alignment Search for optimal alignment of sequences to calculate their percent identity. (BLAST) etc. BLAST can also be used for example to search the query protein sequence of basic organisms against the protein sequence database of various organisms, to find similar sequences. The summary expected value (E value) generated can be used to measure the level of sequence similarity. Because for a specific organism, the protein hit with the lowest E value is not necessarily an ortholog, or is not necessarily a unique ortholog, so mutual query is used to screen the hit sequence with a significant E value to identify an ortholog. Mutual query requires an important hit for the database search of the protein sequence of basic organisms. When the best hit of mutual query is the paralog of query protein itself or query protein, the hit can be identified as an ortholog. Through the mutual query process, the ortholog in all homologs is further distinguished from the paralog, thereby allowing the functional equivalence of the gene to be inferred.
[0101] The term "complementarity percentage" or "complementarity percentage" as used herein with respect to two nucleotide sequences is similar to the concept of identity percentage, but refers to the percentage of nucleotides of the query sequence that are optimally base-paired or hybridized with nucleotides of the target sequence when the query sequence and the target sequence are arranged linearly and optimally base-paired without secondary folded structures such as loops, stems or hairpins. Such a percentage of complementarity can be between two DNA chains, two RNA chains, or between a DNA chain and an RNA chain. "Complementarity percentage" is calculated by (i) optimally base-pairing or hybridizing two nucleotide sequences in a linear and fully extended arrangement (i.e., without folding or secondary structure) over a comparison window, (ii) determining the number of positions of base pairing between the two sequences over the comparison window to produce the number of complementary positions, (iii) dividing the number of complementary positions by the total number of positions in the comparison window, and (iv) multiplying this quotient by 100% to produce the percentage of complementarity of the two sequences. The optimal base pairing of two sequences can be determined based on known pairings achieved by hydrogen bonding of nucleotide bases, such as GC, AT, and AU. If the "complementarity percentage" is calculated relative to a reference sequence without specifying a particular comparison window, the identity percentage is determined by dividing the number of positions that are complementary between the two linear sequences by the total length of the reference sequence. Thus, for the purposes of this disclosure, when two sequences (query and target) are optimally base paired (taking into account mismatches or non-base paired nucleotides, but no folding or secondary structure), the "complementarity percentage" of the query sequence is equal to the number of positions that are base paired between the two sequences divided by the total number of positions in the query sequence over its length (or divided by the number of positions in the query sequence over the comparison window), then multiplied by 100%.
[0102] As used herein, a "fragment" of a polynucleotide refers to a sequence comprising at least about 50, at least about 75, at least about 95, at least about 100, at least about 125, at least about 150, at least about 175, at least about 200, at least about 225, at least about 250, at least about 275, at least about 300, at least about 500, at least about 600, at least about 700, at least about 750, at least about 800, at least about 900 or at least about 1000 consecutive nucleotides or more of a DNA molecule or protein disclosed herein. Methods for generating such fragments from a starting promoter molecule are well known in the art. Fragments of a DNA molecule or protein can exhibit the activity of the DNA molecule or protein from which they are derived.
[0103] The plant selectable marker transgene in the transformation vector or construct of the present disclosure can be used to assist in the selection of transformed cells or tissues due to the presence of a selection agent such as an antibiotic or herbicide, wherein the plant selectable marker transgene provides tolerance or resistance to the selection agent. Thus, the selection agent can favor or favour the survival, development, growth, proliferation, etc. of transformed cells expressing the plant selectable marker gene, such as to increase the proportion of transformed cells or tissues in the R0 plant. Commonly used plant selectable marker genes include, for example, those that confer tolerance or resistance to antibiotics such as kanamycin and paromomycin (nptll), hygromycin B (aph IV), streptomycin or spectinomycin (aadA) and gentamycin (aac3 and aacC4), or those that confer tolerance or resistance to herbicides such as glufosinate (bar or pat), dicamba (DMO) and glyphosate (proA or EPSPS). Plant selectable marker genes that provide the ability to visually screen transformants may also be used, such as luciferase or green fluorescent protein (GFP), or genes expressing beta-glucuronidase for which various chromogenic substrates are known, or the uidA gene (GUS). Plant transformation may also be performed in the absence of selection during one or more steps or stages of culturing the transformed explants, tissues, plants and / or plant parts, allowing the transformed explants, tissues, plants and / or plant parts to develop or regenerate.
[0104] III. Transformation Methods
[0105] Provided are methods and compositions for transforming plant cells, tissues or explants with recombinant DNA molecules or constructs encoded as one or more molecules (e.g., guide RNA and / or site-directed nuclease) required for targeted genome editing. Suitable methods for transforming host plant cells actually include any method (e.g., recombinant DNA constructs are stably integrated into plant chromosomes or recombinant DNA constructs or RNA are transiently provided to plant cells) that can introduce DNA or RNA into cells, and are well known in the art. Two effective methods for cell transformation are bacterial-mediated transformation, such as Agrobacterium (Agrobacterium)-mediated or Rhizobium (Rhizobium)-mediated transformation, and microparticle or particle bombardment-mediated transformation. Microparticle bombardment methods are shown in, for example, U.S. Patent Nos. 5,550,318, 5,538,880, 6,160,208 and 6,399,861. Agrobacterium-mediated transformation methods are described in, for example, U.S. Patent No. 5,591,616. Other methods for plant transformation, such as microinjection, electroporation, vacuum infiltration, pressurization, sonication, silicon carbide fiber agitation, PEG-mediated transformation, etc., are also known in the art.
[0106] The transformation of plant materials is practiced in tissue culture on a nutrient medium (e.g., a mixture of nutrients that allow cells to grow in vitro). Receptor cell targets include, but are not limited to, meristem cells, bud tips, hypocotyls, callus, immature or mature embryos and gametic cells, such as microspores and pollen. Callus can originate from tissue sources including, but not limited to, immature or mature embryos, hypocotyls, seedling apical meristems, microspores, etc. Cells containing transgenic nuclei grow into transgenic plants, also referred to as R0 plants. As used herein, "R0 plants" refers to the transformant initially regenerated. As used herein, "R1 seeds" refers to the seeds produced by selfing R0 plants. As used herein, "R1 plants" refers to plants grown from R1 seeds. As used herein, "R2 seeds" refers to the seeds produced by selfing R1 plants. As used herein, "R2 plants" refers to plants grown from R2 seeds. As provided herein, after one to two generations of selfing of R0 plants, plants homozygous for the edited alleles of the ZmDA1 edited region, free of edited T-DNA sequences, can be produced. In addition, such modified plants can be crossed with different WT male corn plant lines to produce hybrid plants.
[0107] Any suitable method or technique known in the art for transforming plant cells can be used according to the inventive method. In transformation, DNA is usually introduced into only a small percentage of target plant cells in any transformation experiment. Marker genes are used to provide an efficient system for identifying those cells that have been stably transformed by accepting recombinant DNA molecules and integrating the recombinant DNA molecules into their genome.
[0108] As used herein, the term "regeneration" and "regenerating" refers to the process of growing or developing plants from one or more plant cells through one or more culture steps. According to methods known in the art, cells, tissues or explants containing DNA sequence insertion or editing can be grown, developed or regenerated as transgenic plants in culture, containers or soil. Therefore, certain embodiments of the present disclosure relate to methods and constructs for regenerating plants from cells with modified genomic DNA produced by genome editing. Regenerated plants can be used to breed other plants.
[0109] According to one aspect of the present disclosure, regenerated plants or progeny plants, plant parts or seeds thereof can be screened or selected based on markers, traits or phenotypes produced by editing or mutation or by site-directed integration of inserted sequences, transgenes, etc. in the development or regenerated plants or progeny plants, plant parts or seeds thereof. If a given mutation, editing, trait or phenotype is recessive, one or more generations or crosses (e.g., self-pollination) from the initial R0 plant may be required to produce plants homozygous for the editing or mutation so that the trait or phenotype can be observed. The zygosity of progeny plants (such as plants grown from R1 seeds or offspring) can be tested using any known zygosity assay that allows differentiation between heterozygous, homozygous and wild-type plants (such as by using single nucleotide polymorphism (SNP) assays, DNA sequencing, thermal amplification or polymerase chain reaction (PCR) and / or Southern blotting).
[0110] Methods and techniques are provided for screening and / or identifying cells or plants, etc., for the presence of targeted edits or transgenes, and for selecting cells or plants containing targeted edits or transgenes, which can be based on one or more phenotypes or traits, or based on the presence or absence of molecular markers or polynucleotide or protein sequences in cells or plants. As used herein, "molecular techniques" refers to any method known in the fields of molecular biology, biochemistry, genetics, plant biology, or biophysics that involves the use, manipulation, or analysis of nucleic acids, proteins, or lipids. Molecular techniques for detecting the presence of modified sequences in the genome include, but are not limited to, phenotypic screening; molecular marker techniques, such as by or Illumina / Infinium technology; Southern blotting; PCR (including amplicon sequencing, which involves generating one or more unique PCR products across the genomic region of interest for further sequencing analysis, such as using next-generation sequencing technology known in the art. The sequence data from each sample is then mapped to a reference sequence to identify common differences); enzyme-linked immunosorbent assay (ELISA); and sequencing (e.g., Sanger, 454. Pac-Bio and IonTorrent TM ). In one aspect, the detection methods provided herein include phenotypic screening. In another aspect, the detection methods provided herein include SNP analysis. In another aspect, the detection methods provided herein include Southern blotting. In another aspect, the detection methods provided herein include PCR. In another aspect, the detection methods provided herein include amplicon sequencing. In one aspect, the detection methods provided herein include ELISA. In another aspect, the detection methods provided herein include determining the sequence of a nucleic acid or protein. Without limitation, hybridization can be used to detect nucleic acids. Sambrook et al. (1989, Molecular Cloning: A Laboratory Manual, 2nd Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) discuss hybridization between nucleic acids in detail.
[0111] Conventional techniques in the art can be used to isolate nucleic acids. For example, any method including but not limited to recombinant nucleic acid technology and / or PCR can be used to isolate nucleic acids. General PCR techniques are described, for example, in PCR Primer: A Laboratory Manual, Dieffenbach and Dveksler, Cold Spring Harbor Laboratory Press, 1995. Recombinant nucleic acid technology includes, for example, restriction enzyme digestion and ligation, which can be used to isolate nucleic acids. Isolated nucleic acids can also be chemically synthesized in the form of a single nucleic acid molecule or in the form of a series of oligonucleotides.
[0112] Detection (e.g., detection of amplified products, hybridization complexes, polypeptides) can be achieved using detectable labels that can be linked or associated with hybridization probes or antibodies. The term "label" is intended to cover the use of direct labels as well as indirect labels. Detectable labels include enzymes, prosthetic groups, fluorescent materials, luminescent materials, bioluminescent materials, and radioactive materials. Modified (e.g., edited) plants or plant cells can be screened and selected by any method known to those skilled in the art of molecular biology. Examples of screening and selection methods include, but are not limited to, Southern analysis, PCR amplification for detecting polynucleotides (including amplicon sequencing), Northern blotting, RNase protection, primer extension, RT-PCR amplification for detecting RNA transcripts, Sanger sequencing, next generation sequencing techniques (e.g., Ion Torrent TMThe present invention relates to the method for detecting the presence or expression of polypeptides and / or polynucleotides by using a variety of techniques, such as in situ hybridization, enzyme staining, and immunostaining. Methods for performing all of the techniques mentioned are known in the art.
[0113] As used herein, the term "polypeptide" refers to a chain of at least two covalently linked amino acids. The polypeptide can be encoded by a polynucleotide as provided herein. An example of a polypeptide is a protein. The protein as provided herein can be encoded by a nucleic acid molecule as provided herein. The polypeptide can be purified from a natural source (e.g., a biological sample) by known methods such as DEAE ion exchange, gel filtration, and hydroxyapatite chromatography. The polypeptide can also be purified, for example, by expressing a nucleic acid in an expression vector. In addition, purified polypeptides can be obtained by chemical synthesis. The purity of the polypeptide can be measured using any appropriate method (e.g., column chromatography, polyacrylamide gel electrophoresis, or HPLC analysis).
[0114] Antibodies can be used to detect polypeptides. Techniques for using antibodies to detect polypeptides include enzyme-linked immunosorbent assay (ELISA), Western blotting, immunoprecipitation, and immunofluorescence. The antibodies provided herein can be polyclonal antibodies or monoclonal antibodies. Methods well known in the art can be used to produce antibodies with specific binding affinity for the polypeptides provided herein. Methods known in the art can be used to connect the antibodies provided herein to a solid support, such as a microtiter plate.
[0115] IV. Genome-modified plants
[0116] As used herein, "modified" in the context of corn plants, corn plant seeds, corn plant parts, corn plant cells and / or corn plant genomes refers to corn plants, plant seeds, plant parts, plant cells and / or plant genomes that contain engineered changes in the expression level of one or more genes of interest and / or endogenous sequences relative to wild-type or control corn plants, plant seeds, plant parts, plant cells and / or plant genomes. In fact, the term "modified" can further refer to corn plants, plant seeds, plant parts, plant cells and / or plant genomes that have one or more deletions and / or one or more nucleotide substitutions or nucleotide insertions that affect endogenous ZmDA1 genes introduced by chemical mutagenesis, transposon insertion or excision or any other known mutagenesis technology or introduced by genome editing. In one aspect, the modified plants, plant seeds, plant parts, plant cells and / or plant genomes may contain one or more transgenes. Thus, for clarity, modified corn plants, plant seeds, plant parts, plant cells and / or plant genomes include mutant, edited and / or transgenic corn plants, plant seeds, plant parts, plant cells and / or plant genomes having a modified sequence of a ZmDA1 gene relative to a wild-type or control plant, plant seed, plant part, plant cell and / or plant genome. In addition, the modification may reduce, disrupt or alter the activity of a protein encoded by the ZmDA1 gene compared to the activity of the protein encoded by the ZmDA1 gene in an otherwise identical corn plant.
[0117] Modified corn plants, plant parts, seeds, etc. may have been subjected to mutagenesis, genome editing or site-directed integration, genetic transformation, or a combination thereof. Such "modified" corn plants, plant seeds, plant parts, and plant cells include plants, plant seeds, plant parts, and plant cells that are descendants of or derived from "modified" corn plants, plant seeds, plant parts, and plant cells that maintain molecular changes (e.g., changes in expression levels and / or activity) of the ZmDA1 gene. The modified seeds provided herein can produce modified plants provided herein. The modified plants, plant seeds, plant parts, plant cells, or plant genomes provided herein may comprise a recombinant DNA construct or vector or genome editing as provided herein.
[0118] "Modified plant product" can be any product made from a modified plant, plant part, plant cell or plant chromosome as provided herein, or any part or component thereof. For example, in some embodiments, a modified plant product can be a commodity product produced by a modified plant or part thereof containing a recombinant DNA molecule as described herein (such as those provided as SEQ ID NO: 11-49). In some embodiments, a commodity product contains a detectable amount of DNA comprising a DNA sequence selected from a group consisting of SEQ ID NO: 11-49 or its fragments or variants. As used herein, "commodity product" refers to any composition or product comprising a material derived from a modified plant, seed, plant cell or plant part containing a DNA molecule as described herein (such as those provided as SEQ ID NO: 11-49). Commodity products include, but are not limited to, processed seeds, grains, plant parts and meal, protein concentrates, protein isolates, grains, starch, flour, biomass or seed oils. Commodity products containing a detectable amount of DNA corresponding to a recombinant DNA molecule as described herein (such as those provided as SEQ ID NO: 11-49) are contemplated. Detection of one or more of such DNA in a sample can be used to determine the content or origin of a commercial product.Any standard method for detecting DNA molecules can be used, including the detection methods disclosed herein.
[0119] The modified plant can be further hybridized with itself or other plants to produce modified plant seeds and progeny. The modified plant can also be prepared by hybridizing a first plant comprising a DNA sequence or construct or editing (e.g., genomic deletion) with a second plant lacking a DNA sequence or construct or editing. For example, a DNA sequence or inversion can be introduced into a first plant strain that can be subjected to transformation or editing, and then the first plant strain can be hybridized with a second plant strain to infiltrate the DNA sequence or editing (e.g., deletion) into the second plant strain. The progeny of these hybrids can be further backcrossed with desirable strains for multiple times, such as by 6 to 8 generations or 6 to 8 backcrosses, to produce progeny plants with substantially the same genotype as the original parent strain, but with the introduction of a DNA sequence or editing. The modified plant, plant cell or seed provided herein can be a hybrid plant, plant cell or seed. As used herein, a "hybrid" is created by hybridizing two plants from different varieties, strains, inbred lines or species so that the progeny includes genetic material from each parent. The skilled artisan recognizes that higher order hybrids can also be produced.
[0120] The modified corn plants, plant parts, plant cells or seeds provided herein can be of an elite variety or an elite line."Elite variety" or "elite line" refers to a variety that has been produced by breeding and selection for superior agronomic performance.
[0121] As used herein, the term "control plant" (or similarly "control" plant seed, plant part, plant cell and / or plant genome) refers to a corn plant (or plant seed, plant part, plant cell and / or plant genome) used for comparison to a modified plant (or modified plant seed, plant part, plant cell and / or plant genome) and having the same or similar genetic background (e.g., the same parental line, hybrid line, inbred line, tester, etc.) as the modified plant (or plant seed, plant part, plant cell and / or plant genome) except for the genomic edit (e.g., deletion) affecting the ZmDA1 gene. For example, the control plant can be the same inbred line as the inbred line used to prepare the modified corn plant, or the control plant can be the product of a cross between the same inbred parental lines as the modified plant, except that any transgenic event or genomic edit affecting the ZmDA1 gene is absent in the control plant. Similarly, an "unmodified control plant" refers to a plant that shares a substantially similar or essentially identical genetic background with a modified plant, but does not have one or more engineered changes (e.g., mutations or edits) to the genome of the modified plant. For the purposes of comparison with a modified plant, plant seed, plant part, plant cell, and / or plant genome, a "wild-type plant" (or similarly, a "wild-type" plant seed, plant part, plant cell, and / or plant genome) refers to a non-transgenic and non-genome-edited control plant, plant seed, plant part, plant cell, and / or plant genome. As used herein, a "control" plant, plant seed, plant part, plant cell, and / or plant genome may also be a plant, plant seed, plant part, plant cell, and / or plant genome having a similar (but not identical or equivalent) genetic background to a modified plant, plant seed, plant part, plant cell, and / or plant genome if it is deemed to be sufficiently similar for comparison of the feature or trait to be analyzed.
[0122] As used herein, the term "activity" refers to the biological function of a gene or protein. A gene or protein can provide one or more different functions. Therefore, the reduction, destruction or change of "activity" refers to the minimization, reduction or elimination of one or more functions of a gene or protein in a corn plant, a plant cell or a plant tissue at one or more stages of plant development compared with the activity of a gene or protein in a wild type or a control plant, a cell or a tissue at the same stage of plant development. In addition, the increase of "activity" therefore refers to the raising of one or more functions of a gene or protein in a corn plant, a plant cell or a plant tissue at one or more stages of plant development compared with the activity of a gene or protein in a wild type or a control plant, a cell or a tissue at the same stage of plant development.
[0123] According to some embodiments, a modified corn plant is provided having a genomic modification in the ZmDA1 gene that results in a reduction, disruption or alteration of at least 5%, at least 10%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 90% or 100% of the activity of a protein encoded by the ZmDA1 gene in at least one plant tissue as compared to a control plant. According to additional embodiments, a modified corn plant is provided having a protein encoded by the ZmDA1 gene that results in a 5%-20%, 5%-25%, 5%-30%, 5%-40%, 5%-50%, 5%-60%, 5%-70%, 5%-75%, 5%-80%, 5%-90%, 5%-100%, 75%-100%, 50%-100%, 50%-90%, 50%-75%, 25%-75%, 30%-80% or 10%-75% decrease in activity in at least one plant tissue as compared to a control plant.
[0124] According to some embodiments, a modified plant is provided having a ZmDA1 mRNA level reduced or increased by at least 5%, at least 10%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 90%, or 100% in at least one plant tissue compared to a control plant. According to some embodiments, a modified plant is provided having a ZmDA1 mRNA expression level that is reduced or increased by 5%-20%, 5%-25%, 5%-30%, 5%-40%, 5%-50%, 5%-60%, 5%-70%, 5%-75%, 5%-80%, 5%-90%, 5%-100%, 75%-100%, 50%-100%, 50%-90%, 50%-75%, 25%-75%, 30%-80%, or 10%-75% in at least one plant tissue compared to a control plant. According to some embodiments, a modified plant is provided having a ZmDA1 protein expression level that is reduced or increased by at least 5%, at least 10%, at least 20%, at least 25%, at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 75%, at least 80%, at least 90% or 100% in at least one plant tissue compared to a control plant. According to some embodiments, a modified plant is provided having a ZmDA1 protein expression level that is reduced or increased by 5%-20%, 5%-25%, 5%-30%, 5%-40%, 5%-50%, 5%-60%, 5%-70%, 5%-75%, 5%-80%, 5%-90%, 5%-100%, 75%-100%, 50%-100%, 50%-90%, 50%-75%, 25%-75%, 30%-80%, or 10%-75% in at least one plant tissue compared to a control plant.
[0125] The present disclosure relates to plants with improved economically important characteristics (including but not limited to increased yield). More specifically, in terms of yield, the present disclosure relates to modified plants comprising genome editing or mutations as described herein, wherein the plant shows an increase in key yield-related traits, such as the number of grains per ear, the number of grains per longitudinal row of the ear (i.e., grain grade), ear size-related traits (e.g., ear area, ear length and ear diameter), single grain weight, number of grain rows, yield, grain yield estimates per plant and / or grain yield estimates compared to control plants. Many plants of the present disclosure show increased or improved yield trait components compared to control plants. Yield can be defined as a measurable product with economic value from a crop. Yield can be defined in terms of quantity and / or quality. For example, corn yield can include any other similar conversion of grain weight measured per unit area, grain weight per plant, ear number per acre, or harvested grains measured per unit. Yield can be directly dependent on several factors, such as the number and size of organs, plant architecture (such as the number of branches, plant biomass, etc.), flowering period and duration, grain filling period. Root architecture and development, photosynthetic efficiency, nutrient uptake, stress tolerance, early growth vigor, delayed senescence and functional stay-green phenotype can be important factors in determining yield. Therefore, optimizing the above factors can help increase crop yield.
[0126] Modified plants comprising or derived from plant cells comprising the genomic modifications disclosed herein can further enhance stacked traits, such as modified crop plants having enhanced traits resulting from the expression of the DNA disclosed herein in combination with one or more additional genomic modifications that provide beneficial agronomic traits or further improve the enhanced traits.
[0127] Modified plants containing or derived from plant cells transformed with the recombinant DNA of the present disclosure can further enhance stacked traits, such as modified crop plants with enhanced traits resulting from the combined expression of the DNA disclosed herein with one or more genes of interest that provide beneficial agronomic traits to crop plants, such as herbicide and / or pest resistance traits. For example, traits conferred by the recombinant DNA constructs of the present disclosure can be stacked with other traits of interest in agronomy, such as traits that provide insect resistance, such as using genes from Bacillus thuringensis to provide resistance to Lepidoptera, Coleoptera, Homoptera, Hemiptera and other insects, or improved quality traits, such as improved nutritional value. Molecules and methods for conferring insect / nematode / virus resistance are disclosed in US Patent Nos. 5,250,515; 5,880,275; 6,506,599; 5,986,175; and US Patent Application Publication No. 2003 / 0150017A1.
[0128] Herbicides to which transgenic plants have been shown to exhibit tolerance and to which the methods and compositions of the present disclosure can be applied include, but are not limited to, glyphosate, dicamba, glufosinate, sulfonylureas, bromoxynil, norfloxacin, 2,4-D (2,4-dichlorophenoxy)acetic acid, aryloxyphenoxypropionates, p-hydroxyphenylpyruvate dioxygenase inhibitors (HPPD), and protoporphyrinogen oxidase inhibitors (PPO) herbicides. Polynucleotide molecules encoding proteins involved in herbicide tolerance are known in the art and include, but are not limited to, polynucleotide molecules encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) disclosed in U.S. Pat. Nos. 5,094,945, 5,627,061, 5,633,435, and 6,040,497 for conferring glyphosate tolerance; polynucleotide molecules encoding glyphosate oxidoreductase (GOX) disclosed in U.S. Pat. No. 5,463,175 and U.S. Pat. App. No. 2,463,175; and polynucleotide molecules encoding glyphosate oxidoreductase (GOX). The polynucleotide molecules encoding glyphosate-N-acetyltransferase (GAT) disclosed in 003 / 0083480A1 are also used to confer glyphosate tolerance; the polynucleotide molecules encoding dicamba monooxygenase disclosed in U.S. Patent Application Publication No. 2003 / 0135879A1 are used to confer dicamba tolerance; the polynucleotide molecules encoding bromoxynil nitrilase (Bxn) disclosed in U.S. Patent No. 4,810,648 are used to confer bromoxynil tolerance; Misawa et al. (Plant J. 4:833-840, 1993) and Misawa et al. (Plant J. 6:481-489, 1994), which are used to confer tolerance to norfloxacin; Sathasivan et al. (Nucl. Acids Res. 18:2188-2193, 1990), which are used to confer tolerance to sulfonylurea herbicides; DeBlock et al. (EMBO J.6:2513-2519, 1987), which is used to confer tolerance to glufosinate and bialaphos; a polynucleotide molecule disclosed in U.S. Patent Application Publication 2003 / 010609A1, which is used to confer tolerance to N-aminomethylphosphonic acid; a polynucleotide molecule disclosed in U.S. Patent No. 6,107,549, which is used to confer resistance to pyridine herbicides; molecules and methods for conferring tolerance to a variety of herbicides such as glyphosate, atrazine, ALS inhibitors, isoxathiapiprolin and glufosinate herbicides are disclosed in U.S. Patent No. 6,376,754 and U.S. Patent Application Publication 2002 / 0112260.
[0129] Genetic elements, methods and transgenes that confer resistance to fungal diseases may also be used with the present disclosure (e.g., U.S. Pat. Nos. 6,653,280; 6,573,361; 6,506,962; 6,316,407; 6,215,048; 5,516,671; 5,773,696; 6,121,436; 6,316,407; 6,506,962).
[0130] V. Definition
[0131] The following definitions are provided to define and clarify the meaning of these terms with reference to the relevant embodiments of the present disclosure as used herein, and to guide those of ordinary skill in the art to understand the present disclosure. Unless otherwise indicated, terms should be understood according to their conventional meanings and usages in the relevant fields, particularly in the fields of molecular biology and plant transformation.
[0132] When introducing elements of the present disclosure or embodiments thereof, the articles “a,” “an,” “the,” and “said” are intended to mean that there are one or more of the elements.
[0133] The term "and / or" when used in a list of two or more items means any one of the items, any combination of the items, or all of the items associated with this term.
[0134] The terms "comprising", "including" and "having" are intended to be inclusive and mean that there may be additional elements in addition to the listed elements. For example, any method that "comprising", "having" or "includes" one or more steps is not limited to having only those one or more steps and may also encompass other unlisted steps. Similarly, any composition or device that "comprising", "having" or "includes" one or more features is not limited to having only those one or more features and may encompass other unlisted features.
[0135] As used herein, "plant" includes whole plants, explants, plant parts, seedlings or plantlets at any stage of reproduction or development.
[0136] As used herein, "plant part" may refer to any organ or complete tissue of a plant, such as meristem, shoot organ / structure (e.g., leaf, stem or node), root, flower or flower organ / structure (e.g., bract, sepal, petal, stamen, carpel, anther and ovule), seed, embryo, endosperm, seed coat, fruit, mature ovary, propagule or other plant tissue (e.g., vascular tissue, cortical tissue, basic tissue, etc.) or any part thereof. The plant parts of the present disclosure may be viable, non-viable, regenerable, and / or non-regenerable. "Propaganda" may include any plant part that can grow into a whole plant.
[0137] An "embryo" is a portion of a plant seed that consists of precursor tissues (eg, meristems) that can develop into all or part of an adult plant. An "embryo" may further include a portion of a plant embryo.
[0138] "Meristem" or "meristematic tissue" comprises undifferentiated cells or meristematic cells that are capable of differentiating to give rise to one or more types of plant parts, tissues, or structures, such as all or part of a shoot, stem, root, leaf, seed, or the like.
[0139] As used herein, "genomic DNA" or "gDNA" refers to the chromosomal DNA of an organism.
[0140] As used herein, "genomic modification" (also referred to as "modification") or "genomic editing" (also referred to as "editing") refers to any modification of the genomic nucleotide sequence compared to a wild type or control plant. Genomic modification or genome editing includes deletion, insertion, substitution, inversion, duplication or any combination thereof.
[0141] As used herein, "T-DNA" or "transfer DNA" refers to the transfer DNA of the tumor-inducing (Ti) plasmid of certain bacterial species, such as Agrobacterium tumefaciens.
[0142] As used herein, "interfering protein" refers to a protein that contains an alteration that interferes with the normal activity of a protein lacking the alteration (such as a wild-type protein). Non-limiting examples of such interference include reducing or disrupting normal protein-protein interactions of the wild-type protein, binding to protein-protein interaction partners in a non-functional manner, and / or forming non-functional protein complexes.
[0143] As used herein, "dominant effect" refers to the phenomenon that one allele of a gene on a chromosome masks or covers the effect of a different allele of the same gene on another copy of the chromosome."dominant effect" can also refer to the observation of allele-related phenotypes in plants heterozygous for the gene of interest.
[0144] As used herein, "grains per ear" is a measure of the plot average of the number of grains divided by the number of ears.
[0145] As used herein, "kernel grade" is a measure of the number of kernels per longitudinal row of the ear.
[0146] As used herein, "ear area" is the plot average of the ear area measured from a two-dimensional view by imaging the ear and including the kernels and tip void in the area measurement.
[0147] As used herein, "ear length" is a measure of the plot average of ear length measured along a straight line from the tip of the ear to the base of the ear node.
[0148] As used herein, "ear size-related traits" refers to traits such as ear area, ear diameter, and ear length.
[0149] As used herein, "ear diameter" is a measure of the plot average of ear diameter measured as the maximum "wide" axis of the ear at its widest cross-section.
[0150] As used herein, "individual kernel weight" is measured as the plot average of the weight of each kernel, calculated as sample kernel weight (adjusted to standard moisture level) / sample kernel number.
[0151] As used herein, "kernel row number" is the plot average of the number of kernel rows on an ear counted around the circumference of the ear.
[0152] As used herein, "yield" refers to the amount of crop harvested per unit area of land. Non-limiting examples of yield measurements include "grain yield estimate" and "grain yield estimate per plant". Grain yield estimate is a conversion of hand-harvested grain weight measurements per area collected from a small plot of land to equivalent bushels per acre, including adjustment to standard moisture levels. Grain yield estimate per plant is the calculated grain yield of a population of plants (ears) / number of plants (ears) sampled (in ounces).
[0153] "Standard agronomic practices" are known to those skilled in the art and refer to generally accepted methods and techniques for growing and evaluating crop species. For example, field trials conducted under standard agronomic practices carefully control confounding factors, including the environment, so that the trials reflect the intrinsic morphology and physiology of the variety being tested.
[0154] As used herein, the "vegetative stage" of plant development is the growing period between germination and flowering. For corn, a plant development scale commonly used in the art is referred to as the V stage. The V stage is defined based on the uppermost leaf, where the leaf collar is visible. VE corresponds to emergence, V1 corresponds to the first leaf, V2 corresponds to the second leaf, V3 corresponds to the third leaf, and V(n) corresponds to the nth leaf. VT occurs before the last branch of the tassel is visible but the tassel is exposed. When a corn field is staged, each specific V stage is defined only when 50% or more of the plants in the field are at or above that stage. Other developmental scales are known to those skilled in the art and can be used with the methods of the present invention. The stages of corn reproduction are as follows: R1 (silking stage; silk emerges from the husk); R2 (blister stage; kernel is white on the outside and the internal fluid is clear); R3 (milky stage, kernel is yellow on the outside and the internal fluid is milky white); R4 (waxy stage; the milky internal fluid thickens due to starch accumulation); R5 (depression stage; more than 50% of the kernel is depressed); and R6 (physiological maturity; black layer forms). Corn vegetative and reproductive stages are well known to those skilled in the art, and many publications describing these stages can be found on the World Wide Web and elsewhere.
[0155] As used herein, the term "isogenic" means genetically identical, while non-isogenic means genetically different.
[0156] Unless otherwise noted herein or clearly contradictory to context, all methods described herein can be performed in any suitable order. The use of any and all examples or exemplary language (e.g., "such as") provided with respect to certain embodiments herein is intended only to illustrate the present disclosure, and unless otherwise required, the scope of the present disclosure is not limited.
[0157] Example
[0158] Example 1. Design of gene editing constructs
[0159] As described herein, targeted mutagenesis of the ubiquitin receptor gene ZmDA1 in corn using gene editing provides a unique opportunity to regulate cell proliferation and increase corn yield per ear. The edited ZmDA1 gene can encode a modified protein with reduced, damaged or altered activity (e.g., peptidase activity). In addition, this modified protein can interfere with protein-protein interactions and can have a dominant effect on traits related to grain number and ear size, thereby increasing the yield of hybrid corn.
[0160] The coding sequence of the ZmDA1 gene is provided as SEQ ID NO: 1, the amino acid sequence of the ZmDA1 protein is provided as SEQ ID NO: 2, and the genomic DNA (gDNA) sequence of the ZmDA1 gene starting from the start codon of the first exon and ending at the stop codon of the last exon (including introns) is provided as SEQ ID NO: 3, and the coordinates of the exons are described in Table 1. Briefly, "gDNA" represents the ZmDA1 gene; "exon number" means the exon described by the coordinates (in Figure 1 ); and “coordinates” represent nucleotide base positions in the gDNA sequence.
[0161] Table 1. Exon coordinates of the gDNA sequence of the ZmDA1 gene
[0162]
[0163] Regions of the ZmDA1 gene encoding the LIM domain (SEQ ID NO: 3 nucleotide bases 3434-3656), the LIM-like domain (SEQ ID NO: 3 nucleotide bases 3678-4176), or the C-terminal DAl-like domain (SEQ ID NO: 3 nucleotide bases 4216-6811) were targeted for mutagenesis via gene editing to produce interfering proteins. Figure 1 As shown in , three gene editing constructs for plant transformation were designed using multiple guide RNAs (gRNAs) targeting specific positions within a 785 bp region in the ZmDA1 gene starting from 6 nucleotides within the 3' end of the region encoding the LIM domain up to the C-terminal DA1-like domain encoding region.
[0164] Each of the three gene editing constructs is designed to produce a double-strand break (DSB) at the position targeted by the gRNA. Modifications performed by gRNA include deletions with potential reading frame shifts, premature termination sequences, or post-editing alternative splicing at the DSB site. Base changes or insertions are possible around the deletion.
[0165] In this example, three gene editing constructs each contain two to three functional regions or boxes associated with gene editing and the generation of DSBs in the edited ZmDA1 gene region: expression of the Cpf1 protein and expression of one or two guide RNAs targeting the ZmDA1 gene sequence encoding the LIM domain, LIM-like domain, or C-terminal D1-like region. Each guide RNA unit contains a common scaffold compatible with the Cpf1 gene (SEQ ID NO: 4), and a unique spacer / targeting sequence complementary to the expected target site listed in Table 2. Some constructs also contain functional regions or boxes associated with gene editing and the generation of DSBs in genomic regions other than the ZmDA1 gene.
[0166] The Cpf1 expression cassettes of all constructs in Table 2 comprise a maize polyubiquitin promoter (SEQ ID NO: 5) operably linked to two copies of a maize codon-optimized sequence encoding the Lachnospiraceae bacterial Cpf1 RNA-guided endonuclease (SEQ ID NO: 6) fused to a nuclear localization signal (SEQ ID NO: 7) (see, e.g., Gao et al., Nature Biotechnol. 35(8): 789-792, 2017; herein incorporated by reference in its entirety).
[0167] One type of gRNA expression cassette present in construct pC1DA1 comprises a sequence encoding one ZmDA1 guide RNA operably linked to a plant expressible promoter. Two such cassettes are present in pC1DA1 (guide RNA spacers DA1_g+4413 and DA1_g-4348). The spacer sequences listed in Table 2 target alternative DSB sites encoding the LIM domain, LIM-like domain, or C-terminal DA1-like domain region of the ZmDA1 gene. Another type of gRNA expression cassette present in constructs pC2DA1 (guide RNA spacers DA1_g+4413 and DA1_g-4348) and pC3DA1 (guide RNA spacers DA1_g-3673 and DA1_g-4348) comprises a sequence encoding two ZmDA1 guide RNAs operably linked to a plant expressible promoter. The spacer sequences listed in Table 2 target alternative DSB sites encoding the LIM domain, LIM-like domain, or C-terminal DAl-like domain in the ZmDA1 gene. In summary, Table 2 shows exemplary gRNAs for editing the ZmDA1 gene in the region encoding the LIM domain, LIM-like domain, or C-terminal DAl-like domain.
[0168] Table 2. Example guide RNAs for editing the endogenous ZmDA1 gene
[0169]
[0170]
[0171] Example 2. Confirmation of edited alleles in plants produced by gene editing constructs pC1DA1, pC2DA1 and pC3DA1
[0172] An inbred corn plant line (wild type or WT) was transformed via Agrobacterium-mediated transformation with one of the pC1DA1, pC2DA1 or pC3DA1 constructs described above in Example 1. Transformed plant tissue was grown to produce mature plants and subjected to DNA sequencing to screen for genomic modifications in the ZmDA1 gene and all other applicable genomic regions associated with the construct used. After selfing of one to two generations of edited plants, plants homozygous for the edited alleles in the ZmDA1 edited region, containing no editing T-DNA sequences and also containing no genomic modifications outside the ZmDA1 gene were crossed with different WT male corn plant lines to produce hybrid plants.
[0173] To determine edits in the ZmDA1 region encoding the LIM domain, LIM-like domain, and C-terminal DA1-like domain, amplicon sequencing techniques were used to generate sequences for each edited region for comparison with the wild-type sequence. Amplicon sequencing involves generating one or more unique PCR products across the genomic region of interest for further sequencing analysis, such as using Next-Gen Sequencing techniques known in the art. Sequence data from each sample is then mapped to a reference sequence to identify shared differences. Plants with unique modifications were selected to provide diverse coverage of single gene mutations in the targeted genomic region. Table 3 and Table 4 were assayed for these plants. Figure 2 Edited regions and damage reported in .
[0174] Briefly, Table 3 summarizes the edited plants produced by pC1DA1, pC2DA1, and pC3DA1 editing constructs, which perform one or more edits to the ZmDA1 gene in the region encoding the LIM domain, LIM-like domain, or C-terminal D1-like domain; "Editing construct" refers to a construct transformed into a transformant plant to induce one or more edits to the ZmDA1 gene. "Editing Name" is an identifier of the unique edited plant produced (also referred to as "ZmDA1 gene editing" or "ZmDA1 edited plant"); Null_DA1 (WT) corresponds to an unedited wild-type corn plant. "Causal Lesion" indicates the coordinates of the edited gene region, including the size of the nucleotide base pairs. In this regard, "Coordinates" represent the nucleotide base positions in the gDNA sequence (SEQ ID NO: 3) of the ZmDA1 wild-type gene instead of the ZmDA1 gene editing sequence (SEQ ID NO: 11 to SEQ ID NO: 19). Throughout Table 3, "NA" indicates that the identifier is not applicable to WT plants.
[0175] Table 3. Edited plants generated by pC1DA1, pC2DA1 and pC3DA1 editing constructs, the ZmDA1 gene was modified by segment.
[0176]
[0177] Figure 2 Depicts the positional sequence changes in the ZmDA1 gene editing described in Table 3. Figure 2 In the figure, asterisks (*) indicate positions where all edited sequences retain the same bases as WT, lack base deletions, or base changes; and dashes (-) indicate base deletions compared to WT. Several ZmDA1 gene edits contain nucleotide substitutions or nucleotide insertions around the deleted region (DA1_edit4 and DA1_edit9). Most ZmDA1 gene edits involve modifications that cause changes in the C-terminal DA1-like domain of the ZmDA1 protein. DA1_edit4 starts near the end of the region encoding the LIM domain, causing a frame shift and a premature stop codon.
[0178] Example 3. Estimation of grain / ear / yield potential of plants with edited alleles
[0179] Field trials were conducted under standard agronomic practices to evaluate key yield-related traits of hybrid plants containing the ZmDA1 editing region and without the editing T-DNA sequence.
[0180] Maize ear traits were measured at the R6 stage. Ear size-related traits were measured by imaging analysis. Figure 3 The percentage difference (Δ) between edited plants and wild-type control plants is shown in Figure 3 In the figure, dark grey bars indicate significant increases or decreases when the P value is less than 0.2; light grey bars indicate increases or decreases in yield-related traits when the P value is 0.2 or above. Figure 3 The following traits were measured and reported in the experiment: number of kernels per ear; kernel grade; ear area; and ear length. Typically, 128 representative ears (approximately 16 replicates, 8 ears per replicate) were measured for each ZmDA1-edited plant in the experiment.
[0181] Grain yield estimates and grain yield per plant were also determined and reported in Figure 3 Grain yield estimates are conversions from hand-harvested grain weight measurements per area collected from a small plot to equivalent bushels per acre, including adjustments for standard moisture levels. Grain yield estimates per plant are calculated grain yield per plant (ear) population / number of plants (ears) sampled (in ounces).
[0182] like Figure 3As shown in, in most ZmDA1-edited plants, ZmDA1-edited plants showed statistically significant improvements in several yield-related traits compared to control plants, including increased grains per ear, grain grade, ear size-related traits (ear area and ear length), and grain yield estimates per plant. For some specific ZmDA1-edited plants, grain yield estimates were also increased.
[0183] The yield trait data presented in this example demonstrate that targeted editing of the ZmDA1 gene can result in increased grain number and ear size related traits compared to WT controls, indicating that these genome edits can have a dominant effect on increased yield traits.
[0184] Example 4: Design of gene editing constructs pC4DA1, pC5DA1 and pC6DA1
[0185] Three additional gene editing constructs were designed to generate new edited allele variants in the ZmDA1 gene. All three constructs target the ZmDA1 gene region encoding the LIM domain (SEQ ID NO: 3 nucleotide bases 3434-3656), the LIM-like domain (SEQ ID NO: 3 nucleotide bases 3678-4176) or the C-terminal D1-like domain (SEQ ID NO: 3 nucleotide bases 4216-6811) for mutagenesis by gene editing. The three gene editing constructs for plant transformation were designed as described in Example 1 with two guide RNAs (gRNAs) (each DA1_g+4413 and DA1_g-4348).
[0186] In this example, each of the three gene editing constructs contained two functional regions or boxes associated with gene editing and the generation of DSBs in the edited ZmDA1 gene region: expression of the Cpf1 protein and expression of two guide RNAs targeting the ZmDA1 gene sequence encoding the LIM domain, LIM-like domain, or C-terminal D1-like domain region. Each guide RNA unit contained a common scaffold compatible with the Cpf1 gene (SEQ ID NO: 4), and a unique spacer / targeting sequence complementary to the expected target site listed in Table 4. Some constructs also contained functional regions or boxes associated with gene editing and the generation of DSBs in genomic regions other than the ZmDA1 gene (data not shown).
[0187] The Cpf1 expression cassettes of all constructs in Table 4 comprise a maize polyubiquitin promoter (SEQ ID NO: 5) operably linked to two copies of a maize codon-optimized sequence encoding the Lachnospiraceae bacterial Cpf1 RNA-guided endonuclease (SEQ ID NO: 6) fused to a nuclear localization signal (SEQ ID NO: 7) (see, e.g., Gao et al., Nature Biotechnol. 35(8): 789-792, 2017; herein incorporated by reference in its entirety).
[0188] The gRNA expression cassettes present in constructs pC4DA1, pC5DA1, and pC6DA1 contain sequences encoding two ZmDA1 guide RNAs operably linked to a plant expressible promoter. The spacer sequences listed in Table 4 target alternative DSB sites encoding the LIM domain, LIM-like domain, or C-terminal D1-like domain region of the ZmDA1 gene. All three constructs pC4DA1, pC5DA1, and pC6DA1 contain the same two guide RNA spacers: guide RNA spacers DA1_g+4413 and DA1_g-4348. In summary, Table 4 shows exemplary gRNAs for editing the ZmDA1 gene.
[0189] Table 4. Example guide RNAs for editing the endogenous ZmDA1 gene
[0190]
[0191] Example 5. Confirmation of edited alleles in plants produced by gene editing constructs pC4DA1, pC5DA1 and pC6DA1
[0192] Inbred maize plant lines (WT) were transformed with one of the pC4DA1, pC5DA1, or pC6DA1 constructs via Agrobacterium-mediated transformation as described in Example 2. Transformed plant tissues were grown to produce mature R0 plants. Selected R0 plants with one or more unique genome edits were selfed to produce homozygous R1 plants. To determine the edits of the endogenous ZmDA1 gene of the R0 and R1 plants, an amplicon sequencing technique was performed. Table 5 and Figure 4 The edited R1 plants described in Table 6 are the result of transformation with pC4DA1 or pC5DA1. Figure 5 The editing in the R0 plants described in was the result of transformation with pC6DA1.
[0193] Briefly, Table 5 summarizes homozygous edited R1 plants produced by pC4DA1 and pC5DA1 editing constructs that edit the ZmDA1 gene in a region encoding a LIM domain, a LIM-like domain, or a C-terminal DAl-like domain. "Editing construct" refers to a construct that is transformed into a transformant plant to induce one or more edits to the ZmDA1 gene. "Editing Name" is an identifier for the unique edited plant produced (also referred to as "ZmDA1 gene edited" or "ZmDA1 edited plant"); Null_DA1(WT) corresponds to an unedited wild-type corn plant. "Causal Lesion" indicates the coordinates of the edited gene region, including the size of the nucleotide base pairs. In this regard, "Coordinates" represent the nucleotide base position in the gDNA sequence of the ZmDA1 wild-type gene (SEQ ID NO:3) rather than in the ZmDA1 gene editing sequence (SEQ ID NO:20 to SEQ ID NO:38). "NA" indicates that the identifier is not applicable to WT plants. Tables 5 and Figure 4 The coordinates presented in are based on an alignment generated using the MUSCLE (Multiple Sequence Comparison by Logarithmic Expectation) computational alignment method. Clearly misaligned bases at either end of the modification (an accidental byproduct of the multiple sequence alignment method) were manually corrected so that the coordinates reflect the correct position of the modification with reference to SEQ ID NO:3. In some edits, multiple sets of "causal lesion" coordinates are possible because, depending on the alignment method used, the coordinates may differ due to the presence of identical bases at either end of the modification. For example, depending on the alignment method used, the 1 bp deletion contained in DA1_edit19 can be located at bp position 4430 or bp position 4429 with reference to SEQ ID NO:3, depending on the bp position of the "C" nucleotide assigned by the computational alignment method. However, regardless of the alignment method used, all edits are clearly defined by their respective sequences presented in Table 6 by the identifier "SEQ ID NO".
[0194] Table 5. Edited homozygous R1 plants generated by pC4DA1 and pC5DA1 editing constructs, the ZmDA1 gene was modified by segment.
[0195]
[0196]
[0197] DA1_edit20 (SEQ ID NO: 30) was produced separately in separate plants from the two constructs pC4DA1 and pC5DA1, resulting in two plants carrying the same edit. Therefore, they are listed in the same row of Table 5. Figure 4Schematic depiction of aligned position sequence changes in ZmDA1 gene editing described in Table 5. ZmDA1 editing has deletions that may lead to premature translation termination, reading frame shifts, or splice site disruptions.
[0198] In brief, Table 6 summarizes the modifications detected in the edited R0 plants produced by the pC6DA1 editing constructs that edited the ZmDA1 gene in the region encoding the LIM domain, LIM-like domain, or C-terminal DA1-like domain. In the R0 plants, the zygosity of the edited alleles of the ZmDA1 gene has not been determined, so the alleles of the ZmDA1 gene containing edits 29-31 in the edited R0 plants can be heterozygous and / or biallelic. "Editing construct" refers to a construct that is transformed into a transformant plant to induce one or more edits to the ZmDA1 gene. "Editing allele name" is an identifier of the unique edited R0 plant produced. "Modification number" represents an identifier assigned to the damage / modification in the uniquely edited plant. "Causal damage" indicates the coordinates of the edited gene region, including the size of the nucleotide base pairs. In this regard, "coordinates" represent nucleotide base positions in the gDNA sequence of the ZmDA1 wild-type gene (SEQ ID NO: 3) rather than in the ZmDA1 gene edited sequence (SEQ ID NO: 50 to SEQ ID NO: 59). Throughout Table 6, "NA" indicates that the identifier is not applicable to WT plants. Table 6 and Figure 5 The coordinates presented in are based on alignments generated using the MUSCLE (Multiple Sequence Comparison by Logarithmic Expectation) computational alignment method. Clearly misaligned bases at either end of the modification (an accidental byproduct of the multiple sequence alignment method) were manually corrected so that the coordinates reflect the correct position of the modification with reference to SEQ ID NO:3. In some edits, multiple sets of "causal lesion" coordinates are possible because, depending on the alignment method used, the coordinates may differ due to the presence of identical bases at either end of the modification. For example, depending on the alignment method used, the 10 bp deletion contained in DA1_edit29 modification 2 may be located at bp positions 4325 to 4334 or bp positions 4326 to 4335 with reference to SEQ ID NO:3, according to the bp position of the "A" nucleotide assigned by the computational alignment method. However, regardless of the alignment method used, all edits are clearly defined by their respective sequences presented in Table 6 by the identifier "SEQ ID NO". The SEQ ID NOs: (excluding WT plant SEQ ID NO:3) provided in Table 6 reference the sequence results of the amplicon sequencing technology used to detect the modifications (amplicons).
[0199] Table 6. Description of modifications derived from R0 plants transformed with the pC6DA1 editing construct, the ZmDA1 gene was modified in segments.
[0200]
[0201]
[0202] Figure 5 Schematic depiction of the aligned position sequence changes in the ZmDA1 modifications described in Table 6. In order to allow unambiguous assignment of Figure 5 The modifications depicted in Figure 5 The "Edited Allele Name" and "Modification Number" are combined in the sequence to identify the source of the sequence (e.g., "DA1_edit29-1" refers to modification number 1 in the edited allele "DA1_edit29" in Table 6). The ZmDA1 gene edits described have modifications that can result in premature translation termination, reading frame shifts, or splice site disruptions.
[0203] Among the R0 plants produced by the pC6DA1 editing construct that edits the ZmDA1 gene, the modified plants can be selected for continued analysis based on the inclusion of one or more modifications as summarized in Table 6. These R0 plants may include a combination of one or more modifications described in Table 6, depending on the actual zygosity of the alleles of the ZmDA1 gene in the R0 plant. For example, a plant derived from the edited allele "DA1_edit30" may include alleles carrying a combination of one or more of the DA1_edit30 modification numbers 1 to 4 described in Table 6, such as the alleles exemplified in Table 7. In order to obtain plants homozygous for a specific edited allele, the R0 plants produced by the pC6DA1 editing construct can be selfed for one or more generations and subsequently tested for zygosity using any known zygosity assay that allows differentiation between heterozygous, homozygous and wild-type plants. Table 7 summarizes such potential homozygous edited plants that can be obtained from the R0 plants produced by the pC6DA1 editing construct that edits the ZmDA1 gene. "Edited allele name in R0 plant" is an identifier of a unique edited R0 plant produced by the pC6DA1 editing construct. "Edited name of a potential edited homozygous plant" is an identifier of a potential unique edited plant that can be obtained from an R0 plant produced by the pC6DA1 editing construct; Null_DA1 (WT) corresponds to an unedited wild-type corn plant. "Causal lesion" indicates the coordinates of the edited gene region in the R0 plant produced by the pC6DA1 editing construct, including the size of the nucleotide base pairs. As shown in Tables 5 and 6, in this regard, "coordinates" represent the nucleotide base position in the gDNA sequence (SEQ ID NO:3) of the ZmDA1 wild-type gene. "SEQ ID NO:" (in a potential edited homozygous plant)" refers to a potential edited ZmDA1 allele present in a plant that can be obtained from an R0 plant produced by the pC6DA1 editing construct. "SEQ ID NO:" (in the basic amplicon of the produced R0 plant)" refers to the sequence result of the amplicon sequencing technology used to detect modifications (amplicons) in R0 plants produced by the pC6DA1 editing construct.
[0204] Table 7: Potentially edited homozygous plants obtainable from R0 plants generated by the pC6DA1 editing construct, the ZmDA1 gene is modified by a segment
[0205]
[0206] The modified plants can be further self-fertilized or hybridized with other plants to produce modified plant seeds and progeny. Such plant seeds and progeny can be hybrid seeds or plants.
[0207] Field trials can be conducted under standard agronomic practices (e.g., as described in Example 3) to evaluate key yield-related traits of modified plants comprising the ZmDA1 editing region produced by editing constructs pC4DA1, pC5DA1, and / or pC6DA1. These plants are expected to have high yield maize characteristics comparable to those of the previously described modified plants comprising modifications in the ZmDA1 gene produced by editing constructs pC1DA1, pC2DA1, or pC3DA1 (see Examples 2 and 3).
[0208] Implementation
[0209] For further illustration, additional non-limiting embodiments of the present invention are set forth below.
[0210] Embodiment A1 is a modified corn plant, corn plant seed, corn plant part or corn plant cell, comprising a genomic modification that reduces or disrupts the activity of ZmDA1 compared to the activity of ZmDA1 in an otherwise identical corn plant, corn plant seed, corn plant part or corn plant cell lacking the modification.
[0211] Embodiment A2 is a modified plant, plant seed, plant part or plant cell of embodiment A1, wherein the modification is present in at least one allele of the endogenous ZmDA1 gene.
[0212] Embodiment A3 is a modified plant, plant seed, plant part or plant cell of embodiment A1 or A2, wherein the genomic modification is in an endogenous ZmDA1 gene encoding a protein having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:2.
[0213] Embodiment A4 is the modified plant, plant seed, plant part or plant cell of embodiment A2 or A3, wherein the modification is in the transcribable region of the ZmDA1 gene.
[0214] Embodiment A5 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A2 to A4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence for the LIM domain.
[0215] Embodiment A6 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A2 to A4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence for the LIM-like domain.
[0216] Embodiment A7 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A2 to A4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence of the C-terminal DAl-like domain.
[0217] Embodiment A8 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A4 to A7, wherein the modification is in an exon region of the ZmDA1 gene.
[0218] Embodiment A9 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A4 to A7, wherein the modification is in an intron region of the ZmDA1 gene.
[0219] Embodiment A10 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A4 to A7, wherein the modification is in the exon region and intron region of the ZmDA1 gene.
[0220] Embodiment A11 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A1 to A10, wherein said plant, plant seed, plant part or plant cell is heterozygous for said modification.
[0221] Embodiment A12 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A10, wherein the plant, plant seed, plant part or plant cell is homozygous for the modification.
[0222] Embodiment A13 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A11, wherein the plant, plant seed, plant part or plant cell comprises a first modification in a first allele of the ZmDA1 gene and a second modification in a second allele of the ZmDA1 gene, and the first modification and the second modification are different from each other.
[0223] Embodiment A14 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A13, wherein the modification comprises a deletion, insertion, substitution, inversion, duplication or any combination thereof.
[0224] Embodiment A15 is a modified plant, plant seed, plant part or plant cell as described in embodiment 14, wherein the modification is located about 2375 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3.
[0225] Embodiment A16 is a modified plant, plant seed, plant part or plant cell as described in embodiments 1 to 15, wherein the modification comprises deletion, substitution, insertion or any combination thereof.
[0226] Embodiment A17 is the modified plant, plant seed, plant part or plant cell of any one of embodiments A1 to A16, wherein said plant, plant seed, plant part or plant cell comprises a modification in at least one allele of said ZmDA1 gene, wherein said modification is selected from the group consisting of:
[0227] Compared to the reference sequence SEQ ID NO:3, a deletion of 115 base pairs from nucleotide 4322 to nucleotide 4436;
[0228] Compared to the reference sequence SEQ ID NO: 3, a deletion of 10 base pairs from nucleotide 4324 to nucleotide 4333;
[0229] Compared to the reference sequence SEQ ID NO:3, a deletion of 4 base pairs from nucleotide 4430 to nucleotide 4433;
[0230] Compared to the reference sequence SEQ ID NO: 3, a deletion of 7 base pairs from nucleotide 4327 to nucleotide 4333;
[0231] Compared to the reference sequence SEQ ID NO:3, a deletion of 6 base pairs from nucleotide 4429 to nucleotide 4434;
[0232] Compared to the reference sequence SEQ ID NO: 3, a modification of 8 base pairs from nucleotide 3650 to nucleotide 3657;
[0233] Compared to the reference sequence SEQ ID NO: 3, a deletion of 11 base pairs from nucleotide 4327 to nucleotide 4337;
[0234] Compared to the reference sequence SEQ ID NO: 3, a deletion of 10 base pairs from nucleotide 4324 to nucleotide 4333;
[0235] Compared to the reference sequence SEQ ID NO:3, a deletion of 6 base pairs from nucleotide 4426 to nucleotide 4431;
[0236] Compared to the reference sequence SEQ ID NO: 3, a deletion of 113 base pairs from nucleotide 4325 to nucleotide 4437;
[0237] Compared to the reference sequence SEQ ID NO: 3, a deletion of 6 base pairs from nucleotide 4325 to nucleotide 4330;
[0238] Compared to the reference sequence SEQ ID NO:3, a deletion of 6 base pairs from nucleotide 4428 to nucleotide 4433;
[0239] Compared to the reference sequence SEQ ID NO: 3, a deletion of 29 base pairs from nucleotide 4326 to nucleotide 4354;
[0240] Compared to the reference sequence SEQ ID NO: 3, a deletion of 3 base pairs from nucleotide 4429 to nucleotide 4431;
[0241] Compared to the reference sequence SEQ ID NO: 3, a modification of 111 base pairs from nucleotide 4325 to nucleotide 4435; and
[0242] Any combination of them.
[0243] Embodiment A18 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A17, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region between nucleotide positions 3434 and 6811 of the reference sequence SEQ ID NO:3.
[0244] Embodiment A19 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A18, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region between nucleotide positions 3650 and 4437 of the reference sequence SEQ ID NO:3.
[0245] Embodiment A20 is a modified plant, plant seed, plant part or plant cell as described in embodiment A18 or A19, wherein the modification comprises the deletion of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125 or at least 150 consecutive nucleotides.
[0246] Embodiment A21 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A14 to A20, wherein the plant, plant seed, plant part or plant cell comprises a chromosomal sequence in the ZmDA1 gene, which has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity with SEQ ID NO:3 in regions other than deletions, insertions, substitutions, inversions or duplications.
[0247] Embodiment A22 is a modified plant, plant seed, plant part or plant cell of any one of embodiments A1 to A21, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of: SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18 and SEQ ID NO:19.
[0248] Embodiment A23 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A22, wherein the modification destroys or alters the ZmDA1 activity compared to the ZmDA1 activity in an otherwise identical plant, plant seed, plant part or plant cell lacking the modification.
[0249] Embodiment A24 is a modified plant, plant seed, plant part or plant cell of embodiment A23, wherein the modification alters the peptidase activity of ZmDA1.
[0250] Embodiment A25 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments A1 to A24, wherein the modification confers an altered phenotype to the plant compared to the phenotype of an otherwise identical plant lacking the modification.
[0251] Embodiment A26 is a modified plant, plant seed, plant part or plant cell as described in embodiment A25, wherein the altered phenotype comprises an increase in the number of grains per ear, the number of grains per longitudinal row of an ear, ear area, ear length, yield, grain yield estimate per plant, grain yield estimate, or any combination thereof, compared to the phenotype of an otherwise identical plant lacking the modification.
[0252] Embodiment A27 is a modified plant, plant seed, plant part or plant cell of any one of embodiments A1 to A26, wherein the modified plant exhibits increased yield, estimated grain yield per plant, estimated grain yield, or any combination thereof, compared to an otherwise identical plant lacking the modification.
[0253] Embodiment A28 is a polynucleotide sequence comprising a sequence selected from the group consisting of SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18 and SEQ ID NO:19.
[0254] Embodiment A29 is a guide RNA comprising a polynucleotide sequence selected from the group consisting of: SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10.
[0255] Embodiment A30 is a method for producing a corn plant comprising a modified ZmDA1 gene, the method comprising:
[0256] a) introducing a modification that reduces or destroys ZmDA1 activity into at least one target site of an endogenous ZmDA1 gene in a corn plant cell;
[0257] b) identifying and selecting one or more corn plant cells comprising said modification in said ZmDA1 gene of step (a); and
[0258] c) regenerating at least a first plant from said one or more cells selected in step (b) or progeny thereof comprising said modification.
[0259] Embodiment A31 is a method according to embodiment A30, wherein the target site is located in the coding region or the non-coding region of the endogenous ZmDA1 gene.
[0260] Embodiment A32 is a method as described in embodiment A30, wherein the modification is located in the region of the ZmDA1 gene that includes the coding sequence of the LIM domain.
[0261] Embodiment A33 is a method as described in embodiment A30, wherein the modification is located in the region of the ZmDA1 gene that includes the coding sequence of the LIM-like domain.
[0262] Embodiment A34 is a method according to embodiment A30, wherein the modification is in a region of the coding sequence of the ZmDA1 gene comprising a C-terminal DAl-like region.
[0263] Embodiment A35 is a method as described in embodiment A30, wherein introducing the modification comprises using at least one site-specific genome modification enzyme in the plant cell.
[0264] Embodiment A36 is a method as described in embodiment A35, wherein the site-specific genome modification enzyme is selected from the group consisting of: RNA-guided nucleases, zinc finger nucleases, meganucleases, TALE-nucleases, recombinases, transposases, and any combination thereof.
[0265] Embodiment A37 is a method as described in any one of embodiments A35 to A36, wherein the site-specific genome modification enzyme is an RNA-guided nuclease comprising a Cas nuclease, a Cpf1 nuclease, or a variant of either thereof.
[0266] Embodiment A38 is a method as described in any one of embodiments A35 to A37, wherein the site-specific genome modification enzyme produces at least one strand break at the target site.
[0267] Embodiment A39 is a method as described in embodiment A30, wherein the modification is selected from the group consisting of substitution, insertion, inversion, deletion, duplication and combinations thereof.
[0268] Embodiment A40 is a method as described in embodiment A39, wherein the modification is a deletion, substitution, insertion or a combination thereof.
[0269] Embodiment A41 is a method as described in embodiment A40, wherein the deletion comprises a region of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, or at least 150 contiguous nucleotides.
[0270] Embodiment A42 is a method for producing a hybrid corn plant comprising a modified ZmDA1 gene, the method comprising crossing a corn plant comprising the modified ZmDA1 gene with a second non-isogenic corn plant to produce an F1 hybrid corn plant, wherein the modified ZmDA1 gene confers an altered phenotype to the hybrid corn plant compared to the phenotype of an otherwise isogenic hybrid corn plant lacking the modification.
[0271] Embodiment A43 is a method according to embodiment A42, wherein the second non-isogenic corn plant lacks a modified ZmDA1 gene.
[0272] Embodiment A44 is a modified plant, plant seed, plant part or plant cell, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of: SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18 and SEQ ID NO:19.
[0273] Embodiment B1 is a modified corn plant, corn plant seed, corn plant part or corn plant cell comprising a genomic modification that reduces or disrupts the activity of ZmDA1 compared to the activity of ZmDA1 in an otherwise identical corn plant, corn plant seed, corn plant part or corn plant cell lacking the modification.
[0274] Embodiment B2 is the modified plant, plant seed, plant part or plant cell of embodiment B1, wherein the modification is present in at least one allele of the endogenous ZmDA1 gene.
[0275] Embodiment B3 is a modified plant, plant seed, plant part or plant cell of embodiment B1 or B2, wherein the genomic modification is in an endogenous ZmDA1 gene encoding a protein having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:2.
[0276] Embodiment B4 is the modified plant, plant seed, plant part or plant cell of embodiment B2 or B3, wherein the modification is in the transcribable region of the ZmDA1 gene.
[0277] Embodiment B5 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B2 to B4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence for the LIM domain.
[0278] Embodiment B6 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B2 to B4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence for the LIM-like domain.
[0279] Embodiment B7-1 is a modified plant, plant seed, plant part or plant cell of any one of Embodiments B2 to B4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence of the C-terminal DAl-like domain.
[0280] Embodiment B7-2 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B2 to B4, wherein the modification is in the region of the ZmDA1 gene comprising the coding sequence of the LIM domain and / or LIM-like domain and / or C-terminal DAl-like domain or any combination thereof.
[0281] Embodiment B8 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B4 to B7, wherein the modification is in an exon region of the ZmDA1 gene.
[0282] Embodiment B9 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B4 to B7, wherein the modification is in an intron region of the ZmDA1 gene.
[0283] Embodiment B10 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B4 to B7, wherein the modifications are in the exon region and intron region of the ZmDA1 gene.
[0284] Embodiment B11 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B10, wherein said plant, plant seed, plant part or plant cell is heterozygous for said modification.
[0285] Embodiment B12 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B10, wherein said plant, plant seed, plant part or plant cell is homozygous for said modification.
[0286] Embodiment B13 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B11, wherein the plant, plant seed, plant part or plant cell comprises a first modification in a first allele of the ZmDA1 gene and a second modification in a second allele of the ZmDA1 gene, the first modification and the second modification being different from each other.
[0287] Embodiment B14 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B13, wherein the modification comprises a deletion, an insertion, a substitution, an inversion, a duplication or any combination thereof.
[0288] Embodiment B15-1 is a modified plant, plant seed, plant part or plant cell as described in embodiment B14, wherein the modification is located about 2375 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3.
[0289] Embodiment B15-2 is a modified plant, plant seed, plant part or plant cell as described in embodiment B14, wherein the modification is located at about 2369 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3.
[0290] Embodiment B16 is a modified plant, plant seed, plant part or plant cell as described in embodiments B1- to B15-2, wherein the modification comprises deletion, substitution, insertion or any combination thereof.
[0291] Embodiment B17 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B16, wherein said plant, plant seed, plant part or plant cell comprises a modification in at least one allele of said ZmDA1 gene, wherein said modification is selected from the group consisting of:
[0292] a deletion of 115 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 11;
[0293] a 10 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 12;
[0294] a 7 base pair deletion and a 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 13;
[0295] a modification of 8 base pairs and a deletion of 11 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 14;
[0296] a 10 base pair deletion and a 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 15;
[0297] a deletion of 113 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 16;
[0298] a first 6 base pair deletion and a second 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 17;
[0299] a 29 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 18;
[0300] modification of 111 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 19;
[0301] a 10 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 20;
[0302] a 10 base pair deletion and a 9 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 21;
[0303] a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:22;
[0304] a 12 base pair deletion and an 11 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:23;
[0305] an 18 base pair deletion and a 7 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:24;
[0306] a 6 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 25;
[0307] a deletion of 624 base pairs and a deletion of 24 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 26;
[0308] a deletion of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:27;
[0309] a 9 base pair deletion and a 7 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:28;
[0310] a deletion of 1 base pair, wherein the resulting nucleotide sequence is SEQ ID NO:29;
[0311] a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:30;
[0312] a deletion of 4 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:31;
[0313] a deletion of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:32;
[0314] modification of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:33;
[0315] a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:34;
[0316] a deletion of 112 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:35;
[0317] a 3 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:36;
[0318] a deletion of 16 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:37;
[0319] modification of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:38;
[0320] a deletion of 5 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:39;
[0321] a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:40;
[0322] a 5 base pair deletion and a 10 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:41;
[0323] a 234 base pair deletion and a 10 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:42;
[0324] a deletion of 7 base pairs, an insertion of 64 base pairs, and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:43;
[0325] a 234 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:44;
[0326] a deletion of 7 base pairs, an insertion of 64 base pairs, and a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:45;
[0327] a 25 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:46;
[0328] a deletion of 8 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:47;
[0329] a deletion of 25 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:48;
[0330] an 8 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:49;
[0331] as well as
[0332] Any combination of them.
[0333] Embodiment B18 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B1 to B17, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region from nucleotide position 3434 to nucleotide position 6811 with reference to the sequence of SEQ ID NO:3.
[0334] Embodiment B19-1 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B1 to B18, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region from nucleotide position 3650 to nucleotide position 4437 with reference to the sequence of SEQ ID NO:3.
[0335] Embodiment B19-2 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B1 to B18, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region from nucleotide position 3650 to nucleotide position 4443 with reference to the sequence of SEQ ID NO:3.
[0336] Embodiment B20 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B18 or B19-2, wherein the modification comprises the deletion of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, at least 150, at least 200, at least 300, at least 600 or at least 650 consecutive nucleotides.
[0337] Embodiment B21 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B14 to B20, wherein the plant, plant seed, plant part or plant cell comprises a chromosomal sequence in the ZmDA1 gene, the chromosomal sequence having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:3 in the region other than the modification, deletion, insertion, substitution, inversion or duplication.
[0338] Embodiment B22 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B21, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 NO:38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49.
[0339] Embodiment B23 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B22, wherein the modification destroys or alters the ZmDA1 activity compared to the ZmDA1 activity in an otherwise identical plant, plant seed, plant part or plant cell lacking the modification.
[0340] Embodiment B24 is the modified plant, plant seed, plant part or plant cell of embodiment B23, wherein the modification alters the peptidase activity of ZmDA1.
[0341] Embodiment B25 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B24, wherein the modification confers an altered phenotype to the plant compared to the phenotype of an otherwise identical plant lacking the modification.
[0342] Embodiment B26 is a modified plant, plant seed, plant part or plant cell as described in embodiment B25, wherein the altered phenotype comprises an increase in the number of grains per ear, the number of grains per longitudinal row of an ear, ear area, ear length, yield, grain yield estimate per plant, grain yield estimate, or any combination thereof, compared to the phenotype of an otherwise identical plant lacking the modification.
[0343] Embodiment B27 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B1 to B26, wherein the modified plant exhibits increased yield, estimated grain yield per plant, estimated grain yield, or any combination thereof, compared to an otherwise identical plant lacking the modification.
[0344] Embodiment B28-1 is a polynucleotide sequence comprising a sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49.
[0345] Embodiment B28-2 is a polynucleotide sequence as described in embodiment B28-1, wherein the sequence is a modified endogenous ZmDA1 gene.
[0346] Embodiment B29 is a guide RNA comprising a polynucleotide sequence selected from the group consisting of: SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10.
[0347] Embodiment B30 is a method for producing a corn plant comprising a modified ZmDA1 gene, the method comprising:
[0348] a) introducing a modification that reduces or destroys ZmDA1 activity into at least one target site of an endogenous ZmDA1 gene in a corn plant cell;
[0349] b) identifying and selecting one or more corn plant cells comprising said modification in said ZmDA1 gene of step (a); and
[0350] c) regenerating at least a first plant from said one or more cells selected in step (b) or progeny thereof comprising said modification.
[0351] Embodiment B31 is a method according to embodiment B30, wherein the target site is located in the coding region and / or non-coding region of the endogenous ZmDA1 gene.
[0352] Embodiment B32 is a method as described in embodiment B30, wherein the modification is in the region of the ZmDA1 gene that includes the coding sequence of the LIM domain.
[0353] Embodiment B33 is a method as described in embodiment B30, wherein the modification is located in the region of the ZmDA1 gene that includes the coding sequence of the LIM-like domain.
[0354] Embodiment B34-1 is a method as described in embodiment B30, wherein the modification is located in the region of the coding sequence of the ZmDA1 gene including the C-terminal DAl-like region.
[0355] Embodiment B34-2 is a method as described in Embodiment B30, wherein the modification is in a region of the ZmDA1 gene that includes the coding sequence of the LIM domain and / or LIM-like domain and / or C-terminal DAl-like domain or any combination thereof.
[0356] Embodiment B35 is a method as described in any one of embodiments B30 to B34-2, wherein introducing the modification comprises using at least one site-specific genome modification enzyme in the plant cell.
[0357] Embodiment B36 is a method as described in embodiment B35, wherein the site-specific genome modification enzyme is selected from the group consisting of: RNA-guided nucleases, zinc finger nucleases, meganucleases, TALE-nucleases, recombinases, transposases, and any combination thereof.
[0358] Embodiment B37 is a method as described in any one of embodiments B35 to B36, wherein the site-specific genome modification enzyme is an RNA-guided nuclease comprising a Cas nuclease, a Cpf1 nuclease, or a variant of either thereof.
[0359] Embodiment B38 is a method as described in any one of embodiments B35 to B37, wherein the site-specific genome modification enzyme produces at least one strand break at the target site.
[0360] Embodiment B39 is the method of any one of embodiments B30 to B38, wherein the modification is selected from the group consisting of substitution, insertion, inversion, deletion, duplication, and combinations thereof.
[0361] Embodiment B40 is a method as described in embodiment B39, wherein the modification is a deletion, substitution, insertion or a combination thereof.
[0362] Embodiment B41 is a method as described in embodiment B40, wherein the deletion comprises a region of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, at least 150, at least 200, at least 300, at least 600, or at least 650 contiguous nucleotides.
[0363] Embodiment B42 is a method for producing a hybrid corn plant comprising a modified ZmDA1 gene, the method comprising crossing a corn plant comprising the modified ZmDA1 gene with a second non-isogenic corn plant to produce an F1 hybrid corn plant, wherein the modified ZmDA1 gene confers an altered phenotype to the hybrid corn plant compared to the phenotype of an otherwise isogenic hybrid corn plant lacking the modification.
[0364] Embodiment B43 is a method according to embodiment B42, wherein the second non-isogenic corn plant lacks a modified ZmDA1 gene.
[0365] Embodiment B44 is a modified plant, plant seed, plant part or plant cell, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49.
[0366] Embodiment B45-1 is a modified plant, plant seed, plant part or plant cell, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59.
[0367] Embodiment B45-2 is a modified plant, plant seed, plant part or plant cell as described in embodiment B44 or B45-1, wherein the modified plant, plant seed, plant part or plant cell is a modified corn plant, corn plant seed, corn plant part or corn plant cell.
[0368] Embodiment B46 is a modified corn plant, plant seed, plant part or plant cell comprising a genomic modification in at least one allele of an endogenous ZmDA1 gene.
[0369] Embodiment B47 is a modified corn plant, plant seed, plant part or plant cell as described in embodiment B46, wherein the modified allele of the endogenous ZmDA1 gene reduces or disrupts the ZmDA1 activity compared to the ZmDA1 activity in an otherwise identical corn plant, corn plant seed, corn plant part or corn plant cell lacking the modification.
[0370] Embodiment B48 is a modified corn plant, plant seed, plant part or plant cell as described in any one of embodiments B46 or B47, wherein the modified allele confers an altered phenotype to the plant compared to the phenotype of an otherwise identical plant lacking the modification.
[0371] Embodiment B49 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B46 to B48, wherein the altered phenotype comprises an increase in the number of grains per ear, the number of grains per longitudinal row of an ear, ear area, ear length, yield, grain yield estimate per plant, grain yield estimate, or any combination thereof, compared to the phenotype of an otherwise identical plant lacking the modification.
[0372] Embodiment B50 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B46 to B49, wherein the modification is located about 2375 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3.
[0373] Embodiment B51 is a modified plant, plant seed, plant part or plant cell as described in any one of embodiments B46 to B49, wherein the modification is located about 2369 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO:3.
[0374] Embodiment B52 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B46 to B51, wherein said plant, plant seed, plant part or plant cell comprises a modification in at least one allele of said ZmDA1 gene, wherein said modification is contained within the genomic region from nucleotide position 3434 to nucleotide position 6811 with reference to the sequence of SEQ ID NO:3.
[0375] Embodiment B53 is a modified plant, plant seed, plant part or plant cell of any one of embodiments B46 to B52, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region from nucleotide position 3650 to nucleotide position 4437 with reference to the sequence of SEQ ID NO:3.
[0376] Embodiment B54 is the modified plant, plant seed, plant part or plant cell of any one of embodiments B46 to B52, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is contained within the genomic region from nucleotide position 3650 to nucleotide position 4443 with reference to the sequence of SEQ ID NO:3.
[0377] Embodiment B55 is a modified corn plant, plant seed, plant part or plant cell of any one of embodiments B46 to B54, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 ID NO:38, SEQ ID NO:39, SEQ ID NO:40, SEQ ID NO:41, SEQ ID NO:42, SEQ ID NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48, SEQ ID NO:49.
[0378] Embodiment B56 is a modified corn plant, plant seed, plant part or plant cell of any one of embodiments B46 to B54, wherein the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18 and SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 ID NO:38, SEQ ID NO:50, SEQ ID NO:51, SEQ ID NO:52, SEQ ID NO:53, SEQ ID NO:54, SEQ ID NO:55, SEQ ID NO:56, SEQ ID NO:57, SEQ ID NO:58, SEQ ID NO:59.
[0379] As provided herein, genome editing of the ZmDA1 gene can be used to develop high-yield corn by modulating the ubiquitin pathway. The generation of non-functional interfering proteins in corn plants using ZmDA1 gene editing provides a unique strategy and a significant advance in increasing corn yield.
[0380] Having described the present disclosure in detail, it is apparent that modifications, variations and equivalent embodiments are possible without departing from the spirit and scope of the present disclosure described herein and in the appended claims. In addition, it should be understood that all embodiments in the present disclosure are provided as non-limiting examples.
Claims
1. A modified corn plant, corn plant seed, corn plant part or corn plant cell comprising a genomic modification that reduces or disrupts the activity of ZmDA1 compared to the activity of ZmDA1 in an otherwise identical corn plant, corn plant seed, corn plant part or corn plant cell lacking the modification.
2. The modified plant, plant seed, plant part or plant cell of claim 1, wherein the modification is present in at least one allele of the endogenous ZmDA1 gene.
3. The modified plant, plant seed, plant part or plant cell of claim 1, wherein the genomic modification is in an endogenous ZmDA1 gene encoding a protein having at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:
2.
4. The modified plant, plant seed, plant part or plant cell of claim 2, wherein the modification: i) in the transcribable region of the ZmDA1 gene; ii) in the region of the coding sequence of the ZmDA1 gene comprising the LIM domain; iii) in the region of the coding sequence of the ZmDA1 gene comprising the LIM-like domain; iv) in the region of the coding sequence of the ZmDA1 gene comprising the C-terminal DAl-like domain; or v) any combination thereof.
5. The modified plant, plant seed, plant part or plant cell of claim 4, wherein the modification is in the region of: i) the exon region of the ZmDA1 gene; ii) an intron region of the ZmDA1 gene; or iii) the exon region and intron region of the ZmDA1 gene.
6. The modified plant, plant seed, plant part or plant cell of claim 1, wherein: i) said plant, plant seed, plant part or plant cell is heterozygous for said modification; ii) said plant, plant seed, plant part or plant cell is homozygous for said modification; iii) the plant, plant seed, plant part or plant cell comprises a polynucleotide sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 OR iv) said modified plant exhibits increased yield, estimated grain yield per plant, estimated grain yield, or any combination thereof, compared to an otherwise identical plant lacking said modification.
7. The modified plant, plant seed, plant part or plant cell of claim 6, wherein the plant, plant seed, plant part or plant cell comprises a first modification in a first allele of the ZmDA1 gene and a second modification in a second allele of the ZmDA1 gene, the first modification and the second modification being different from each other.
8. The modified plant, plant seed, plant part or plant cell of claim 1, wherein the modification: i) contains deletion, insertion, substitution, inversion, duplication or any combination thereof; ii) located about 2369 nucleotides or more upstream of the 3' end of the reference sequence SEQ ID NO: 3; iii) located about 3650 nucleotides or more downstream of the 5' end of the reference sequence SEQ ID NO: 3; iv) contains deletions, substitutions, insertions or any combination thereof; v) disrupting or altering the activity of ZmDA1 compared to the activity of ZmDA1 in an otherwise identical plant, plant seed, plant part or plant cell lacking the modification; or vi) conferring an altered phenotype on said plant compared to the phenotype of an otherwise identical plant lacking said modification.
9. The modified plant, plant seed, plant part or plant cell of claim 2, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein the modification is selected from the group consisting of: a deletion of 115 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 11; a 10 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 12; a 7 base pair deletion and a 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 13; a modification of 8 base pairs and a deletion of 11 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 14; a 10 base pair deletion and a 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 15; a deletion of 113 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 16; a first 6 base pair deletion and a second 6 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 17; a 29 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 18; modification of 111 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 19; a 10 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 20; a 10 base pair deletion and a 9 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 21; a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:22; a 12 base pair deletion and an 11 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:23; an 18 base pair deletion and a 7 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:24; a 6 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO: 25; a deletion of 624 base pairs and a deletion of 24 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO: 26; a deletion of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:27; a 9 base pair deletion and a 7 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:28; a deletion of 1 base pair, wherein the resulting nucleotide sequence is SEQ ID NO:29; a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:30; a deletion of 4 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:31; a deletion of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:32; modification of 7 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:33; a deletion of 108 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:34; a deletion of 112 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:35; a 3 base pair deletion and a 4 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:36; a deletion of 16 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:37; modification of 8 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:38; a deletion of 5 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:39; a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:40; a 5 base pair deletion and a 10 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:41; a 234 base pair deletion and a 10 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:42; a deletion of 7 base pairs, an insertion of 64 base pairs, and a deletion of 3 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:43; a 234 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:44; a deletion of 7 base pairs, an insertion of 64 base pairs, and a deletion of 10 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:45; a 25 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:46; a deletion of 8 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:47; a deletion of 25 base pairs and a modification of 9 base pairs, wherein the resulting nucleotide sequence is SEQ ID NO:48; an 8 base pair deletion and a 3 base pair deletion, wherein the resulting nucleotide sequence is SEQ ID NO:49; and Any combination of them.
10. The modified plant, plant seed, plant part or plant cell of claim 2, wherein the plant, plant seed, plant part or plant cell comprises a modification in at least one allele of the ZmDA1 gene, wherein: i) the modification is contained within the genomic region from about nucleotide position 3434 to about nucleotide position 6811 with reference to the sequence of SEQ ID NO:3; or ii) the modification is contained within the genomic region between about nucleotide position 3650 and about nucleotide position 4437 of the reference sequence SEQ ID NO:3; or iii) the modification is contained within the genomic region from about nucleotide position 3650 to about nucleotide position 4443 of the reference sequence SEQ ID NO:
3.
11. The modified plant, plant seed, plant part or plant cell of claim 8, wherein: i) the modification comprises the deletion of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, at least 150, at least 200, at least 300, at least 600, or at least 650 consecutive nucleotides; ii) the plant, plant seed, plant part or plant cell comprises a chromosomal sequence in the ZmDA1 gene, which has at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5% or 100% sequence identity to SEQ ID NO:3 in the region outside of the modification; iii) the modification alters the peptidase activity of ZmDA1; or iv) the altered phenotype comprises an increase in the number of kernels per ear, the number of kernels per longitudinal row per ear, ear area, ear length, yield, an estimate of kernel yield per plant, an estimate of kernel yield, or any combination thereof, compared to the phenotype of an otherwise identical plant lacking the modification.
12. The modified plant, plant seed, plant part or plant cell of claim 8, wherein: i) the modification is contained within the genomic region from about nucleotide position 4325 to about nucleotide position 4433 with reference to the sequence of SEQ ID NO:3; ii) the modification is contained within the genomic region from about nucleotide position 4107 to about nucleotide position 4437 of the reference sequence SEQ ID NO:3; or iii) the modification is contained within the genomic region from about nucleotide position 4326 to about nucleotide position 4433 of the reference sequence SEQ ID NO:
3.
13. A polynucleotide sequence comprising a sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45 NO:43, SEQ ID NO:44, SEQ ID NO:45, SEQ ID NO:46, SEQ ID NO:47, SEQ ID NO:48 and SEQ ID NO:
49.
14. The polynucleotide sequence of claim 13, wherein the sequence is a modified endogenous ZmDA1 gene.
15. A method for producing a corn plant comprising a modified ZmDA1 gene, the method comprising: a) introducing a modification that reduces or destroys ZmDA1 activity into at least one target site of an endogenous ZmDA1 gene in a corn plant cell; b) identifying and selecting one or more corn plant cells comprising said modification in said ZmDA1 gene of step (a); and c) regenerating at least a first plant from said one or more cells selected in step (b) or progeny thereof comprising said modification.
16. The method of claim 15, wherein: i) the target site is located in the coding region and / or non-coding region of the endogenous ZmDA1 gene; ii) the modification is located in the region of the coding sequence of the ZmDA1 gene comprising the LIM domain; iii) the modification is located in the region of the coding sequence of the ZmDA1 gene comprising the LIM-like domain; iv) the modification is located in a region of the coding sequence of the ZmDA1 gene comprising the C-terminal DA1-like region; v) introducing said modification comprises using at least one site-specific genome modification enzyme in said plant cell; vi) the modification is selected from the group consisting of substitution, insertion, inversion, deletion, duplication and combinations thereof; or vii) The modification is deletion, substitution, insertion or a combination thereof.
17. The method of claim 16, wherein the site-specific genome modification enzyme: i) selected from the group consisting of: an RNA-guided nuclease, a zinc finger nuclease, a meganuclease, a TALE-nuclease, a recombinase, a transposase, and any combination thereof; ii) is an RNA-guided nuclease, including a Cas nuclease, a Cpf1 nuclease, or a variant of any of them; or iii) generating at least one strand break at said target site.
18. The method of claim 16, wherein the deletion comprises a region of at least 1, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, at least 80, at least 85, at least 90, at least 95, at least 100, at least 125, at least 150, at least 200, at least 300, at least 600, or at least 650 contiguous nucleotides.
19. A method for producing a hybrid corn plant comprising a modified ZmDA1 gene, the method comprising crossing a corn plant comprising the modified ZmDA1 gene with a second non-isogenic corn plant to produce an F1 hybrid corn plant, wherein the modified ZmDA1 gene confers an altered phenotype to the hybrid corn plant compared to the phenotype of an otherwise isogenic hybrid corn plant lacking the modification.
20. The method of claim 19, wherein the second non-isogenic corn plant lacks a modified ZmDA1 gene.
